Section 35

EurekaMag Full Text Articles Chapter 34,919


Fukuda, M.; Uchida, G.; Sato, T.; Tsunoda, K.; Tanifuji, M. 2001: Face representation in macaque inferotemporal cortex revealed by optical imaging of intrinsic signal. Society for Neuroscience Abstracts 27(1): 1048
Burns, J.A.; Brostrom, G.M. 2000: Face seal for respirator. Official Gazette of the United States Patent and Trademark Office Patents 1230(4)
Salatka, R.G.; Buck, W.B. 2003: Face shield and face shield support assembly. Official Gazette of the United States Patent and Trademark Office Patents 1270(3)
Mordon, S. 2003: Face-lifting lasers: technical principles and characteristics. Annales de Dermatologie et de Venereologie 130(3): 381-384
Marinkovic, K.; Vignal, J.P.; Trebon, P.; Chauvel, P.; Halgren, E. 1999: Face-processing in the human prefrontal cortex Intracerebral stimulation, potentials and lesion deficits. Society for Neuroscience Abstracts 25(1-2): 2149
Suzuki Nishimura, T.; Asakura, W.; Watanabe, S. 2003: Face-to-face consultation meetings on new biotechnological/biological products in Japan. Journal of Pharmacological Sciences 91(Suppl I): 285P
Hamann, D.; Roos, M.T.; van Lier, R.A. 1999: Faces and phases of human CD8 T-cell development. Immunology Today 20(4): 177-180
Reiley, M.A. 2003: Facet arthroplasty devices and methods. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)
Dudasik, M. 2003: Facet fixation devices. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)
Tuite, M.J. 2004: Facet joint and sacroiliac joint injection. Seminars in Roentgenology 39(1): 37-51
Fitz, W.R. 2000: Facet joint pain relief method and apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1230(2)
Goble, E.M.; Fallin, T.W.; Hoy, R.W. 2003: Facet joint replacement. Official Gazette of the United States Patent and Trademark Office Patents 1271(3)
Seiler, G.; Hani, H.; Scheidegger, J.; Busato, A.; Lang, J. 2001: Facet joint tropism in degenerative lumbosacral disc disease in the German Shepherd Dog. Veterinary Radiology and Ultrasound 42(2): 172
Messmer, D.; Messmer, B.T.; Chiorazzi, N. 2002: Facets of Dendritic Cell Maturation Environmental Instructions Lead to Distinct Transcriptional Patterns. Blood 100(11): Abstract No. 1791
Mathis, J.; Loher, T.; Strub, M.; Bassetti, C.; Gugger, M.; Hess, C.W. 2002: Facets of daytime sleepiness. Journal of Sleep Research 11(Suppl 1): 149
Messmer, D.; Messmer, B.; Chiorazzi, N. 2003: Facets of dendritic cell maturation Environmental instructions lead to distinct transcriptional pattern in myeloid dendritic cells. Chiorazzi, Nicholas , Reprint Author, Lahita, Robert G, Capra, J Donald, Ferrarini, Manlio, Zabriskie, John B Immune mechanisms and disease: 309-311
Eliasova, H.; Dvooak, D.; Prochazka, O. 2003: Facial 3D reconstruction. Forensic Science International 136(Suppl 1): 177-178
Hoover, J.E.; Cai, J.; Cargile, C.B.; Thomas, G.H.; Jabs, E.W.; Hamosh, A. 2000: Facial Dysgenesis A new facial syndrome with absent eyes and palpebral fissures, presence of proboscis, square stoma and clefting. American Journal of Human Genetics 67(4 Suppl 2): 122
Ito, K.; Ikadai, K. 2002: Facial aesthetic treatment apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)
Farrar, C.W.; Bell, H.K.; Dobson, C.M.; Sharpe, G.R. 2003: Facial and axillary acne agminata. British Journal of Dermatology 149(5): 1076
Gerald, M.S.; Lyons, H.; Treier, K.M.; Robbins, K.L. 2003: Facial and sexual skin color components correlate with body measures and measures of immune function in free-ranging juvenile female rhesus macaques. American Journal of Primatology 60(Suppl 1): 145
Russell, J.A.; Bachorowski, J.-A.; Fernandez-Dols, J.-M. 2003: Facial and vocal expressions of emotion. Annual Review of Psychology 54: 329-349
Díaz-Romero, R.M.; Garza-Morales, S.; Mayén-Molina, D.G.; Ibarra-Puig, J.; Avila-Rosas, H. 1999: Facial anthropometric measurements in offspring of epileptic mothers. Archives of Medical Research 30(3): 186-189
Wealthall, R.J. 2004: Facial bone modeling and muscle attachment in the juvenile pig. Journal of Morphology 260(3): 339
Olhoffer, I.H.; Davidson, D.; Longley, J.; Glusac, E.J.; Leffell, D. 1999: Facial bowenoid papulosis secondary to human papillomavirus type 16. British Journal of Dermatology 140(4): 761-762
Banks, T.E. 2002: Facial cleanser and method of treating skin conditions. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)
Saavedra, D.; Cornejo, L.; De La Fuente, B.; Ortiz Monasterio, F.; Muenke, M. 2000: Facial clefting syndrome A new autosomal recessive entity in Mexican population. American Journal of Human Genetics 67(4 Suppl 2): 140
Springer, G.E. 2001: Facial contact electrode. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)
Ermis, I.; Topalan, M. 2000: Facial contour restoration with free flaps. Microsurgery 20(6): 285
Levine, M.E.; Stern, R.M.; Burke, K.E. 2000: Facial cooling in the prophylaxis of gastric tachyarrhythmia and the symptoms of motion sickness. Psychophysiology 37(Suppl 1): S63
Levine, M.E.; Williamson, M.J.; Burke, K.E.; Stern, R.M. 2001: Facial cooling prevents the development of gastric tachyarrhythmia during exposure to provocative motion. Gastroenterology 120(5 Suppl 1): A 719
Fitzek, M.M.; Mukai, S.; Buzney, S.M.; Pruett, R.C.; Adams, J.; Munzenrider, J.E. 1999: Facial development after proton irradiation for retinoblastoma Results in six patients with median follow-up of nine years. International Journal of Radiation Oncology Biology Physics 45(3 Suppl): 402-403
Stovak, M.L.; Roush, M.B. 2000: Facial droop in a collegiate baseball player. Medicine and Science in Sports and Exercise 32(5 Suppl): S75
Temtamy, S.A. 2001: Facial dysmorphism and quasidominant inheritance in Cenani-Lenz syndrome. European Journal of Human Genetics 9(Suppl 1): P0520
D.L., P.; Cormier Daire, V.; Fournet, J.C.; Brunelle, F.; Nihoul Fekete, C.; Junien, C.; Robert, J.J.; Saudubray, J.M. 2000: Facial dysmorphism in persistent hyperinsulinemic hypoglycemia. Journal of Inherited Metabolic Disease 23(Suppl 1): 174
Kini, U.; Adab, N.; Vinten, J.; Fryer, A.; Clayton Smith, J. 2003: Facial dysmorphology as a predictor of cognitive impairment in Fetal Anticonvulsant Syndrome. Journal of Medical Genetics 40(Suppl 1): S43
Renault, F. 2001: Facial electromyography in newborn and young infants with congenital facial weakness. Developmental Medicine and Child Neurology 43(6): 421-427
Lerbaek, A.; Agner, T. 2004: Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus. British Journal of Dermatology 150(6): 1210-1211
Burrows, A.M.; Smith, T.D. 2003: Facial expression musculature in Otolemur with a comparison to the lemuroids. American Journal of Physical Anthropology Suppl (36): 72-73
Loeches, A.; Iglesias, J.; Serrano, J.M.; Fernandez Carriba, S. 2002: Facial expression of emotions in human and non-human primates A phylogenetic approach. Folia Primatologica 72(6): 360-361
Padberg, F.; Juckel, G.; Praessl, A.; Zwanzger, P.; Mavrogiorgou, P.; Hegerl, U.; Hampel, H.; Moeller, H.J. 1999: Facial expressions and mood after repetitive transcranial magnetic stimulation of the prefrontal cortex. Society for Neuroscience Abstracts 25(1-2): 2149
Schienfenhoevel, W. 2004: Facial expressions perspectives from human ethology. Epilepsia 45(Suppl 3): 13
Vig, K.W.; Fields, H.W. 2000: Facial growth and management of orthodontic problems. Pediatric Clinics of North America 47(5): 1085-1123
O'higgins, P.; Collard, M. 1999: Facial growth and sexual dimorphism in some Papionin species. American Journal of Physical Anthropology (Suppl 28): 214
Mason, P.T. 1999: Facial heat transfer device with plural containers. Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1346
Bastir, M.; Rosas, A. 2004: Facial heights Implications of postnatal ontogeny and facial orientation for skull morphology in humans and chimpanzees. American Journal of Physical Anthropology Suppl (38): 60-61
Martineau, M.R.; Chapman, M.S. 2002: Facial herpes simplex: autoinoculation by an intubation mask. Journal of Trauma 53(2): 389-390
Leo, D.; Winter, A. 2002: Facial icepack. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)
Lalonde, J.; Liu, C.H.; Collins, C.A.; Chaudhuri, A. 2000: Facial identity can be defined by texture gradients alone. IOVS Investigative Ophthalmology and Visual Science 41(4): S223
Ruifrok, A.; Goos, M.; Hoogeboom, B.; Vrijdag, D.; Bijhold, J. 2003: Facial image comparison using a 3D laser scanning system. Forensic Science International 136(Suppl 1): 29
Barton, J.J.S.; Cherkasova, M.V. 2002: Facial imagery, perception, and covert recognition in prosopagnosia. Neurology 58(7 Suppl 3): A266-A267
Crawley, J.M.; Zukowski, S.L. 2001: Facial implant having one porous surface. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)
Barker, T.A. 2001: Facial injury Football. Medicine and Science in Sports and Exercise 33(5 Suppl): S309
Gebhard, A. 1999: Facial iron. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)
Mohamed, K.B. 2001: Facial lesions resembling leprosy. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 69(1): 35-37
Groenke, A.W. 1999: Facial mask for respiratory apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1220(5): 4161
Berthon Jones, M.; Calluaud, M.; Lynch, C.E.; Hely, K.F. 2000: Facial masks for assisted respiration or CPAP. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)
Tso, Wang Kuo 2001: Facial massager. Official Gazette of the United States Patent and Trademark Office Patents 1242(4)
Barton, S.E.; Chard, S. 2002: Facial molluscum: treatment with cryotherapy and podophyllotoxin. International Journal of Std and Aids 13(4): 277-278
Goudy, A.B.; Freeman, P.W. 1999: Facial morphology and echolocation in chiroptera. Bat Research News 40(4): 172
Streif, R.; Schwaiger, F.W.; Brook, G.A.; Stuermer, C.A.O.; Kreutzberg, G.W.; Hager, G. 1999: Facial motor neurons increase the synthesis of the cell adhesion molecule SCI/ALCAM after injury. Society for Neuroscience Abstracts 25(1-2): 1264
Madlom, M.M.; Hoggard, N.; Griffiths, P.D.; Chan, J. 2003: Facial naevus flammeus with choroidal haemangioma and without intracranial involvement. Developmental Medicine and Child Neurology 45(2): 139
O-Lee, T.J.; Rowe, M.; Perez, D. 2004: Facial nail-gun injury. Journal of Trauma 56(6): 1371-1372
Ikeda, K.; Watabe, K.; Aoki, M.; Sakamoto, T.; Ishigaki, A.; Nagai, M.; Kamii, R.; Iwasaki, Y.; Satoyoshi, E.; Itoyama, Y. 2003: Facial nerve avulsion accelerates motoneuron degeneration in pre-symptomatic transgenic rats expressing mutant human Cu/Zn superoxide dismutase. Annals of Neurology 54(Suppl 7): S53
Kis, Z.; Farkas, T.; Toldi, J.; Grimm, U.; Wolff, J.R. 2000: Facial nerve injury-induced changes in the primary motor cortex in adult rats. European Journal of Neuroscience 12(Suppl 11): 333
Bryant, S.M.; Cumpston, K.; Mycyk, M.B.; Leikin, J.B.; Rezak, M.; Pallasch, E. 2002: Facial nerve neuritis secondary to ultraviolet radiation. Journal of Toxicology. Clinical Toxicology 40(5): 677-678
Michotte, A.; Hoorens, A.; Chaskis, C.; Van Rompaey, K.; Goossens, A.; Desprechins, B.; D'haens, J. 2000: Facial nerve palsy as the presenting manifestation of a cerebellopontine angle meningeal melanocytoma. Brain Pathology 10(4): 589
Halperin, J.J. 2003: Facial nerve palsy associated with lyme disease. Muscle and Nerve 28(4): 516-517
Freilich, E.; Mandelbaum, D.E.; Malholtra, A. 2003: Facial nerve palsy caused by Lyme disease LP or no LP? That was our question. Annals of Neurology 54(Suppl 7): S131
Biezeveld, M.H.; Voorbrood, B.S.; Clur, S.-A.B.; Kuijpers, T.W. 2002: Facial nerve palsy in a thirteen-year-old male youth with Kawasaki disease. Pediatric Infectious Disease Journal 21(5): 442-443
Kimura, H.; Ito, E.; Ishikawa, K.; Kawatani, M. 2003: Facial nerve recovery in guinea pig and neurotrophic effect of PACAP. Regulatory Peptides 115(1): 49, 15 August
Zachariah, J.; Patel, P. 2003: Facial pain with recurrent facial palsy. Headache 43(6): 700-701
Z'graggen, W.J.; Humm, A.M.; Glocker, F.X.; Roesler, K.M. 2003: Facial palsy during pregnancy Clinical and electrophysiological characterization. European Journal of Neurology 10(Suppl 1): 181-182
Melero, G.A.; March, A.R.; Aldrich, I.; Pinedo, J.T. 2000: Facial paralysis: An unusual presentation of congenital cholesteatoma. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 122(4): 615-616
Kikuchi, M.; Higurashi, N.; Miyazaki, S.; Itasaka, Y.; Chiba, S.; Nezu, H. 2001: Facial pattern of sleep breathing disordered children using Ricketts method. Sleep 24(Abstract Suppl): A214
Horn, D.; Weschke, B.; Zweier, C.; Rauch, A. 2004: Facial phenotype allows diagnosis of Mowat-Wilson syndrome in the absence of Hirschsprung disease. American Journal of Medical Genetics. Part a 124a (1): 102-104
Chomczyk, I.; Hubert, E.; Posmyk, R.; Burak, E.; Midro, A.T. 2001: Facial photoanthropometric findings in a group of healthy newborns. European Journal of Human Genetics 9(Suppl 1): P0623
Coulson, I.H.; Khan, A.S. 1999: Facial 'pillow' dermatitis due to lavender oil allergy. Contact Dermatitis 41(2): 111
Zack, P. 1999: Facial prototyping on a desktop personal computer Application in dysmorphology. Journal of Medical Genetics 36(Suppl 1): S68
Miller, K.W.P.; Taister, M.A.; Kelliher, T.; Tu, P. 2003: Facial reconstruction of human remains using deformation modes. Forensic Science International 136(Suppl 1): 179-180
Messenger, D. 2001: Facial skin dermabrasion cleansing and conditioning composition. Official Gazette of the United States Patent and Trademark Office Patents 1250(3)
Wong, C.P.; Chui, P.T.; Karmakar, M.K. 2003: Facial skin injuries caused by adhesive tapes in a patient receiving cosmetic skin exfoliants. Anesthesia and Analgesia 97(5): 1310-1311
Akbal, C.; Tekgul, S.; Atsu, N.; Ozden, E.; Ergen, A.; Kendi, S. 2001: Facial sling cystouretropexy in children with sphincteric incontinence. European Urology 39(Suppl 5): 157
Ashmore, T.H.; Gilliland, G.D.; Gilliland, G.D. 1999: Facial support mask accommodating prone position surgery. Official Gazette of the United States Patent and Trademark Office Patents 1227(1)
Burke, R.E. 1999: Facial toning system. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)
Morris, P.J.; Bradley, J.A.; Doyal, L.; Earley, M.; Hagan, P.; Milling, M.; Rumsey, N. 2004: Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation 77(3): 330-338
Dotan, S. 2000: Facial treatment implement and method. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Fauchald, K. 2001: Facial tubercles in scale worms. American Zoologist 41(6): 1440-1441
Henry, T.R.; Kluin, K.J.; Katariwala, N.M. 2001: Facial, glossal, and palatal paresis in temporal lobe epilepsy. Neurology 56(8 Suppl 3): A138
Williams, F.L. 2003: Facial-masticatory ontogeny in Australopithecus and Pan. American Journal of Physical Anthropology Suppl (36): 225-226
Yagishita, K. 2004: Facies architecture related to sea-level changes of the Upper Cretaceous Taneichi Formation, northeast Japan evidence of actual sea-level fluctuation during the Late Cretaceous. Proceedings of the Japan Academy B Physical and Biological Sciences 80(5): 230-235
Gupta, A.K.; Hengeveld, J.E.; Kemp, A.E.; Premchandran, R.; Thomas, A.V. 2000: Facile N-demethylation of erythromycins for the synthesis of prokinetic macrolides. Abstracts of Papers American Chemical Society 219(1-2): ORGN 524
Bhat, B.A.; Sahu, D.P. 2003: Facile access to pentasubstituted pyridines and tetrasubstituted pyrimidines via oxidative aromatization. Medicinal Chemistry Research 12(4-5): 259-260
Hong, B.C.; Shr, Y.J.; Liao, J.H. 2002: Facile access to the frameworks of aplysin and pannellin via the microwave effected cycloaddition of fulvenes. Abstracts of Papers American Chemical Society 224(1-2): ORGN 704
Steiner, D.D.; Ivison, L.; Goralski, C.T.; Appell, R.B.; Singaram, B. 2002: Facile and efficient approach to the isolation of enantio- and diastereopure limonene oxide. Abstracts of Papers American Chemical Society 223(1-2): ORGN 381
Stewart, J.; Katsuyama, I.; Zjawiony, J.K. 2001: Facile and efficient dibromination of O-methyl-L-tyrosine in aqueous solution. Abstracts of Papers American Chemical Society 222(1-2): ORGN145
Burton, G.; Cao, P.; Li, G.; Rivero, R. 2002: Facile and efficient microwave induced Knoevenagel condensation of aromatic ketones and their application in parallel synthesis of olefinic arylidienes. Abstracts of Papers American Chemical Society 223(1-2): MEDI 85
Jiang, Y.Y.; Li, Q.; Lu, W.; Cai, J.C. 2003: Facile and efficient total synthesis of -cryptotanshinone and tanshinone IIA. Tetrahedron Letters 44(10): 2073-2075, 3 March
Ravi Kumar, J.S.; O'sullivan, M.F.; Reisman, S.E.; Hulford, C.A.; Ovaska, T.V. 2002: Facile approach to the bicyclo decane ring system; efficient synthesis of -7-epi-beta-bulnesene. Tetrahedron Letters 43(11): 1939-1941, 11 March
Hruby, V.J.; Han, G.; Soloshonok, V. 1999: Facile asymmetric synthesis beta-substituted phenylalanines. Abstracts of Papers American Chemical Society 217(1-2): MEDI 228
Avivi, L.; Dotan, A.; Ravia, Y. 2004: Facile detection of cancer and cancer risk based on level of coordination between alleles. Official Gazette of the United States Patent and Trademark Office Patents 1287(2)
Fliss, M.S.; Usadel, H.; Caballero, O.; Wu, L.; Buta, M.; Eleff, S.; Jen, J.; Sidransky, D. 2000: Facile detection of homoplasmic mitochondrial DNA mutations in primary tumors and bodily fluids. Proceedings of the American Association for Cancer Research 41: 235
Choe, Y.S.; Shin, Y.S.; Shin, Y.H.; Choi, Y.; Lee, K.H.; Kim, S.E.; Kim, B.T. 1999: Facile dispensing of FDG using a disposable three-way stopcock. Journal of Labelled Compounds and Radiopharmaceuticals 42(Suppl 1): S856-S857
Ovaska, T.V.; Reisman, S.E.; Flynn, M.A. 2001: Facile entry to the tetracyclic 5-7-6-3 tigliane ring system. Organic Letters 3(1): 115-117
Megdal, P.A.; Siemsen, D.; Sands, D.; Dratz, E.A.; Handelman, G.J. 2010: Facile fingerstick insulin analysis: Application to monitoring postprandial insulin responses to snack foods. Journal of Diabetes 2(1): 28-35
Govindan, S.V.; Goldenberg, D.M.; Stein, R.; Hansen, H.J.; Griffiths, G.L. 1999: Facile lutetium-177 labelings of humanized monoclonal antibodies for radioimmunotherapy. Journal of Nuclear Medicine 40(5 Suppl): 217P
He, S.; Bauman, D.; Davis, J.S.; Gronlund, J.L.; Meng, F.; Loyola, A.; Reinberg, D.; Kelleher, N.L.; Mccafferty, D.G. 2003: Facile method for the total synthesis of site-specifically modified histone proteins. Abstracts of Papers American Chemical Society 226(1-2): BIOL 184
Thomas, R.M.; Thomas, T.; Shirahata, A.; Thomas, T.J. 1999: Facile nuclear delivery of a triplex forming oligonucleotide in breast cancer cells by a novel polyamine analog. Proceedings of the American Association for Cancer Research 40: 587
Fouad, M.; Mamer, O.; Sauriol, F.; Ruhenstroth Bauer, G. 2001: Facile one-step preparation of proteolytic resistant lipids. Abstracts of Papers American Chemical Society 222(1-2): ORGN462
Bolzati, C.; Boschi, A.; Uccelli, L.; Duatti, A.; Giganti, M.; Franceschini, R.; Piffanelli, A. 1999: Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. Journal of Nuclear Medicine 40(5 Suppl): 315P
Kraft, A. 2003: Facile procedure for determining the pKa of weakly acidic pharmaceutical drugs and supramolecular ligands. Abstracts of Papers American Chemical Society 225(1-2): ORGN 110
Zhu, L.; Anslyn, E.V. 2004: Facile quantification of enantiomeric excess and concentration with indicator-displacement assays: an example in the analyses of alpha-hydroxyacids. Journal of the American Chemical Society 126(12): 3676-3677
Chen, W.; Metcalf, M.; Zhao, N.; Mackerell, A.D.; Coop, A. 2002: Facile rearrangement of 5-silylthebaine. Drug and Alcohol Dependence 66(Suppl 1): S31
Majumdar, K.C.; Ghosh, M.; Jana, M.; Saha, D. 2002: Facile regioselective synthesis of 2H-thiopyrano quinolin-5 -ones by thio-Claisen rearrangement. Tetrahedron Letters 43(11): 2111-2113, 11 March
Sai, H.; Ohmizu, H. 1999: Facile stereoselective syntheses of - and -alpha-substituted cinnamates by stereoselective dehydration reaction with 1-ethyl-3- carbodiimide. Tetrahedron Letters 40(27): 5019-5022
Weitman,M.; Lerman,L.; Cohen,S.; Nudelman,A.; Major,D.T.; Gottlieb,H.E. 2010: Facile structural elucidation of imidazoles and oxazoles based on NMR spectroscopy and quantum mechanical calculations -catalyzed cycloisomerization of N-propargylamides. Tetrahedron: 7, 1465-1471
Carballeira, N.M.; Emiliano, A.; Guzman, A. 1999: Facile syntheses for -5,9-hexadecadienoic acid, -5,9-nonadecadienoic acid, and -5,9-eicosadienoic acid through a common synthetic route. Chemistry and Physics of Lipids 100(1-2): 33-40
Chung, S.K.; Kwon, Y.U.; Lee, C. 2002: Facile syntheses of all possible enantiomeric pairs of conduritol and inositol stereoisomers from myo-inositol. Abstracts of Papers American Chemical Society 223(1-2): CARB 64
Klaffke, W.; Ernst, C.; Natsch, S. 2001: Facile syntheses of nucleoside diphosphate activated D- and L-hexoses. Abstracts of Papers American Chemical Society 221(1-2): CARB 76
Ma, D.; Wu, W.; Deng, P. 2001: Facile synthesis of -alpha-allokainic acid via Pd-catalyzed hydrogenolysis of allyl acetate derived from trans-4-hydroxy-L-proline. Tetrahedron Letters 42(39): 6929-6931, 24 September
Shimizu, T.; Seki, M. 2000: Facile synthesis of -biotin via Fukuyama coupling reaction. Tetrahedron Letters 41(26): 5099-5101, 24 June
Vardhan Reddy, K.V.; Ashok, D. 2000: Facile synthesis of 2-benzoyl-6-hydroxy-3-methyl-5- benzo furans. Abstracts of Papers American Chemical Society 219(1-2): ORGN 518
Rao, Rangineni Sunil 2000: Facile synthesis of 7- -2-benzoyl-3-methyl-5H-furo- benzopyran-5-ones. Abstracts of Papers American Chemical Society 219(1-2): ORGN 564
Kitade, Y.kio; Kozaki, Atushi; Yatome, Chizuko 2001: Facile synthesis of 9- -2-hydroxy-3-oxocyclopentan-1-yl-9-H-adenine possessing inhibitory activity against human recombinant S-adenosyl-L-homocysteine hydrolase. Tetrahedron Letters 42(3): 433-435, 15 January
Chen, S.T.; Tseng, M.J.; Sookkheo, B. 2000: Facile synthesis of L-homophenylalanine by equilibrium shift enzymatic reaction using engineered tyrosine aminotransferase. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)
Wang, Q.; Dau, M.E. Tran, H. Sasaki, N.A.; Potier, P. 2001: Facile synthesis of N-Boc- -5- proline. Tetrahedron 57(30): 6455-6462, 23 July
Oguz, U.; Mclaughlin, M.L. 2003: Facile synthesis of a constrained aza-dipeptide. Biopolymers 71(3): 350
Dal Pozzo, A.; Hong Ni, M.; Broxterman, Q.B.; Kaptein, B.; Formaggio, F. 2002: Facile synthesis of a homo-peptide containing seven consecutive sterically hindered residues of C-alfa-methyl valine via the azido/bromide method. Journal of Peptide Science 8(Suppl): S82
Liu, J.; Zhu, L.; Medina, J.C. 2000: Facile synthesis of alpha,alpha-bis alcohols from esters. Abstracts of Papers American Chemical Society 219(1-2): MEDI 221
Hwang, S.H.; Blaskovich, M.; Kim, H.O. 2001: Facile synthesis of alpha-amino alcohols from alpha-amino acids. Abstracts of Papers American Chemical Society 221(1-2): ORGN 89
Mizutani, H.; Takayama, J.; Soeda, Y.; Honda, T. 2002: Facile synthesis of enantiopure -TAN1251A. Tetrahedron Letters 43(13): 2411-2414, 25 March
Banik, B.K.; Banik, I.; Wilson, M. 2003: Facile synthesis of heterocycles by indium-induced reduction-rearrangement of the nitro beta-lactams. Abstracts of Papers American Chemical Society 225(1-2): ORGN 386
Weir, M.D.; Khatri, C.A.; Antonucci, J.M. 2001: Facile synthesis of hydroxylated dimethacrylates for use in biomedical applications. Abstracts of Papers American Chemical Society 222(1-2): POLY 412
Cherivirala, H.K.; Krupadanam, D.G.L. 1999: Facile synthesis of oxygen heterocycles from 7-hydroxy-3-methyl/ethyl-2 -2-phenyl-1-ethenyl-4H-4-chromenones. Abstracts of Papers American Chemical Society 218(1-2): ORGN 653
Oguz, U.; Mclaughlin, M.L. 2003: Facile synthesis of protected hydrazino amino acids. Biopolymers 71(3): 345
Simoni, D.; Rondanin, R.; Furno, G.; Aiello, E.; Invidiata, F.P.olo 2000: Facile synthesis of pyrazoles and pyrroles via thermolysis of tetrazolo pyridazines, tetrazolo pyrimidines and tetrazolo pyridines. Tetrahedron Letters 41(15): 2699-2703
Aoyagi, Y.taka; Mizusaki, Toshihiko; Shishikura, Masahiro; Komine, Takashi; Ohta, Akihiro 2000: Facile synthesis of pyrroles and indoles via palladium-catalyzed oxidation of hydroxy-enamines and amines. Abstracts of Papers American Chemical Society 220(Part 2): ORGN 462
Chovatia, P.T.; Purohit, D.H.; Joshi, H.S. 2003: Facile synthesis of some new pyrazoline as a biological active agent. Medicinal Chemistry Research 12(6-7): 323
Fu, Y.; Miller, T.J.; Hammarstrom, L.G.J.; Mclaughlin, M.L.; Hammer, R.P. 2001: Facile synthesis of sterically hindered alpha,alpha-disubstituted amino acids and their incorporation into peptides by solid phase peptide synthesis. Abstracts of Papers American Chemical Society 222(1-2): ORGN26
Randhawa, S. 2002: Facile synthesis of the biphenyl isostere of calcitonin agonist GW 817. Abstracts of Papers American Chemical Society 224(1-2): ORGN 658
Worley, S.D.; Elrod, D.B. 1999: Facile synthetic approach to imidazolidinone biocides. Abstracts of Papers American Chemical Society 218(1-2): ORGN 626
Pal, A.; Gupta, P.D.; Roy, A.; Mukherjee, D. 1999: Facile total synthesis of -alpha-herbertenol, -alpha-cuparenone and -HM-1 methyl ether involving alkylation of hindered esters. Tetrahedron Letters 40(25): 4733-4734
Lee, H.K.; Chun, J.S.; Pak, C.S. 2000: Facile transformation of 3,4-disubstituted 2-azetidinones to chiral 2-piperidones. Abstracts of Papers American Chemical Society 220(Part 2): ORGN 103
Inamoto, S.; Takahashi, M.; Nakashima, M.N.; Nakashima, K.I.hiro 2000: Facilitaion by various stresses of the expression of the reverse tolerance to ambulation-accelerating effect of methamphetamine in mice. Japanese Journal of Pharmacology 82(Suppl 1): 227P
Hasegawa, T.; Nakayama, M.; Numata, M.; Kawaguchi, Y.; Hosoya, T. 1999: Facilitated IL-1beta production from mononuclear cells in peritoneal dialysate - ex vivo study. Nephron 81(4): 456-457
Futatsugi, A.; Kato, K.; Ogura, H.; Mikoshiba, K. 1999: Facilitated LTP and inhibited LTD in the hippocampus CA1, and altered spatial learning in type 3 ryanodine receptor deficient mice. Society for Neuroscience Abstracts 25(1-2): 1493
Casella, G.; Capecchi, A.; Ottani, F.; Sangiorgio, P.; Pavesi, P.C.; Bracchetti, D. 2002: Facilitated PTCA in acute myocardial infarction A meta-analysis of available studies. European Heart Journal 23(Abstract Suppl): 24
Servatius, R.J.; Beck, K.D. 2004: Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1beta. Integrative Physiological and Behavioral Science: the Official Journal of the Pavlovian Society 38(3): 169-178
Auge, M.; Wicke, C.; Hermann, R.; Wessel, K. 2003: Facilitated administration of alpha-lipoic acid or derivatives thereof. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)
Gibson, C.M.; Murphy, S.A.; James, D.; Marble, S.J.; Wong, G.C.; Kalapanda, R.; Kraimer, N.; Antmen, E.M. 2002: Facilitated angioplasty is associated with an improvement in the number of frames required for dye to fill the mycocardium in ST segment elevation myocardial infarction. Circulation 106(19): II598
Asfour, A.I.; Greenbaum, A.B.; Mcfarland, T.M.; Lemay, M.; Painter, J.A.; Kieval, J.; Stebbins, A.; Weaver, W.D.uglas 2002: Facilitated angioplasty with combined ADP P2T receptor blockade and fibrinolysis for the treatment of acute myocardial infarction Results from the STEP-AMI trial. Journal of the American College of Cardiology 39(5 Suppl A): 39A
Wu, Y.; Tamma, S.L.; Lima, V.; Coico, R. 1999: Facilitated antigen presentation by B cells expressing IgD responding T cells express upregulated IgD-receptors. FASEB Journal 13(4 Part 1): A629
Luca, M.E.; Drijfhout, J.W.; Koning, F.; Nagelkerken, L. 2000: Facilitated antigen presentation by mannosylation of antigens leads to partial tolerance induction in EAE. Journal of Investigative Dermatology 114(1): 231
Deuber, H.J.; Schneider, I.; Meinel, K.; Markau, S.; Rettkowski, O.; Schnepp, M.; Osten, B. 1999: Facilitated assessment of renal function by determination of serum cystatin C levels. Kidney and Blood Pressure Research 22(4-6): 227-228
Casavant, D.A. 1999: Facilitated atrial pacing threshold testing. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)
Matz, J.M.; Kilmore, M. 2001: Facilitated case-study format increases endocrine comprehension in a large first-year medical physiology course. FASEB Journal 15(4): A409
Khersonsky, S.M.; Jung, D-Woon.; Kang, T-Wook.; Walsh, D.P.; Moon, H-Sang.; Jo, H.; Jacobson, E.M.; Shetty, V.; Neubert, T.A.; Chang, Y-Tae. 2003: Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. Journal of the American Chemical Society 125(39): 11804-11805
Dittmar, K.M.; Xie, J.; Li, K.C.P. 2003: Facilitated gene transfection of tumor cells in mice using pulsed high intensity focused ultrasound and an intravenous injection of plasmid. Proceedings of the American Association for Cancer Research 44: 1302-1303
Scotcher, D.; Hall, G.; Jerman, D. 2002: Facilitated peer group supervision for genetic counsellors One years experience. European Journal of Human Genetics 10(Suppl 1): 321
Li, R.H.; Herrmann, H.C. 2000: Facilitated percutaneous coronary intervention: a novel concept in expediting and improving acute myocardial infarction care. American Heart Journal 140(6 Suppl): S125-S135
Dudek, D.; Zmudka, K.; Kaluza, G.L.; Kuta, M.; Pieniazek, P.; Przewlocki, T.; Zorkun, C.; Legutko, J.; Gajos, G.; Bartuś, S.; Bryniarski, L.; Dziewierz, A.; Pasowicz, M.; Dubiel, J.S. 2003: Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. American Journal of Cardiology 91(2): 227-229
Dudek, D.; Zmudka, K.; Kuta, M.; Dziewierz, A.; Zorkun, C.; Bartus, S.; Tracz, W.; Dubiel, J.S. 2002: Facilitated percutaneous coronary interventions in patients with acute myocardial infarction transferred from remote hospitals. European Heart Journal 23(Abstract Suppl): 342
Lambert, T.N.; Boon, J.M.; Smith, B.D.; Pérez-Payán, M.N.; Davis, A.P. 2002: Facilitated phospholipid flip-flop using synthetic steroid-derived translocases. Journal of the American Chemical Society 124(19): 5276-5277
Ernst, N.M.S.K.J.; De Boer, M.J.; Van De Wetering, H.; Hollak, F.; Kolkman, J.J.E.; Van't Hof, A.W.J. 2003: Facilitated primary coronary angioplasty Shortest ischaemic times and best outcome in patients recruited in the ambulance. European Heart Journal 24(Abstract Suppl): 703
Timmis, S.B.; Timmis, G.C.; Pica, M.C.; Flynn, M.S.; Tober, R.B.; O'neill, W.W. 2001: Facilitated primary percutaneous intervention in acute myocardial infarction using glycoprotein IIb/IIIa inhibitors with or without thrombolytic therapy. Circulation 104(17): 2; 504
Lopez, C.B.; Fernandez Sesma, A.; Schulman, J.L.; Moran, T.M. 1999: Facilitated recovery from heterosubtypic influenza virus infection following immunization with virus infected New York. FASEB Journal 13(4 Part 1): A633
Lopez, C.B.; Fernandez Sesma, A.; Schulman, J.L.; Moran, T.M. 2000: Facilitated recovery from heterosubtypic influenza virus infection following immunization with virus infected dendritic cells. Journal of Investigative Dermatology 114(1): 235
Kang, M.Joo.; Eum, J.Yoon.; Jeong, M.Sook.; Choi, S.Eun.; Park, S.Han.; Cho, H.In.; Cho, C.Sung.; Seo, S.Jun.; Lee, M.Won.; Choi, Y.Wook. 2010: Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biological and Pharmaceutical Bulletin 33(1): 100-106
Auge, B.K.; Wu, N.Z.; Dahm, P.; Preminger, G.M. 2001: Facilitated ureteroscopy with a new access sheath. Journal of Endourology 15(Suppl 1): A129
Byrne, R.R.; Kourambas, J.; Auge, B.K.; Munver, R.; Preminger, G.M. 2000: Facilitated ureteroscopy with an access sheath. Journal of Endourology 14(Suppl 1): A52
Neri Souza, A.J.; Godinho, A.G.; Ramos, N.B.; Rabelo, A. 2002: Facilitated versus primary percutaneous coronary interventions A meta-analysis. Circulation 106(19): II536
Schuchert, M.J.; Wright, R.D.; Colson, Y.L. 1999: Facilitating cell surface markers parallel early T cell development. FASEB Journal 13(4 Part 1): A615
Cramer, D.E.; Schanie, C.L.; Grimes, H.L.; Ildstad, S.T. 2001: Facilitating cells potentiate long-term self-renewal of hematopoietic stem cells. Journal of Human Virology 4(3): 139
Sun, Y. 2003: Facilitating data exchange and integration through automated concept matching. Pediatric Research 53(4 Part 2): 165A-166A
Wu, S.; Adams, J.S. 2001: Facilitating effects of intracellular vitamin D binding protein 1 on vitamin D-1-hydroxylation. Journal of Bone and Mineral Research 16(Suppl 1): S556
Redmond, K. 2001: Facilitating patient choice An imperative for cancer nurses. European Journal of Cancer 37(Suppl 6): S386
Helm, D.J. 2002: Facilitating plant community development on anthropogenic disturbances using seed and appropriate growth media. Arctic Science Conference Abstracts 53: 114
Voevodskaya, M.; Lindeman, D.H.; Wheeler, S. 2002: Facilitating scientific and technical research with the Former Soviet Union. Arctic Science Conference Abstracts 53: 230
Drolet, P.; Girard, M.; Poirier, J.; Grenier, Y. 2000: Facilitating submental endotracheal intubation with an endotracheal tube exchanger. Anesthesia and Analgesia 90(1): 222-223
Naimark, D.M.J.; Bott, M.T.; Tobe, S.W. 2002: Facilitating the adoption of microalbuminuria screening among type II diabetic patients in primary care Preliminary results of a randomized educational intervention trial. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 638A
Johnston, P.E.J.; Dale, V.H.M.; Love, S. 2002: Facilitating the development of communication skills in veterinary undergraduates. Research in Veterinary Science 72(Suppl A): 3
Schlegel, W.M.; O'loughlin, V.D.; Robinson, J.M. 2002: Facilitating the scholarship of teaching and learning with course portfolios. FASEB Journal 16(5): A755-A756
Nesbitt, T. 2000: Facilitating the work of northern collaborative research boards The culture of research. Arctic Science Conference Abstracts 51: 43-44
O'connell, D. 2002: Facilitating translational research The patient/advocate input. European Journal of Cancer 38(Suppl 3): S129
Griffiths, P.D. 2002: Facilitating viral recombination. Reviews in Medical Virology 12(6): 335-336
Lortie, C.J.; Turkingtom, R. 2001: Facilitation among annual plants in the Negev desert. Ecological Society of America Annual Meeting Abstracts 86: 145
Sakai, K.L.; Takeuchi, T.; Watanabe, E. 2000: Facilitation and inhibition of syntactic processing by local transcranial magnetic stimulation of Brocas area. Neuroscience Research Suppl (24): S53
Steinmetz, J.; Soluk, D.A.; Kohler, S.L. 2002: Facilitation between herons and bass on common minnow prey Death from above and below. Ecological Society of America Annual Meeting Abstracts 87: 274
Sekiya, Y.miko; Nakagawa, Takayuki; Ozawa, Tohru; Minami, Masabumi; Satoh, Masamichi 2003: Facilitation by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate of morphine withdrawal symptoms and a rewarding effect of morphine in rats. Journal of Pharmacological Sciences 91(Suppl I): 90P
Queiroz, G.; Diniz, C.; Fresco, P.; Goncalves, J. 1999: Facilitation by adenosine of noradrenaline release in rat isolated vas deferens is prevented by blockade of alpha2-autoreceptors. British Journal of Pharmacology 127(Proceedings Suppl ): 115P
Umeda, M.; Tashima, K.; Yamamoto, H.; Araki, H.; Takeuchi, K. 1999: Facilitation by endogenous prostaglandins of capsaicin-induced cytoprotection in the rat stomach through EP2 receptor subtype. Gastroenterology 116(4 Part 2): A937
Nakashima, M.; Ogawa, Y.; Kato, S.; Takeuchi, K. 2002: Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection through EP2 and IP receptors Study using rats and knockout mice. Gastroenterology 122(4 Suppl 1): A-512-A-513
Murray, C.; Emmanuel, N.D.ss A.; Sanger, G.J. 2002: Facilitation by ghrelin and metoclopramide of nerve-mediated excitatory responses in mouse gastric fundus circular muscle. British Journal of Pharmacology 136(Proceedings Suppl): 18P
Carmen, M.; Dimitry, V.; Amal, B.K.; Bibiane, S.F.; Claudia, L.; Nathan, D.; Schreibmayer, W. 2000: Facilitation of GIRK activation by cAMP dependent proteinkinase. Biophysical Journal 78(1 Part 2): 464A
Shah, N.; Thomas, T.; Thomas, T.J. 1999: Facilitation of NF-kappaB-DNA binding by polyamines in breast cancer. Breast Cancer Research and Treatment 57(1): 137
Haughey, N.J.; Mattson, M.P.; Nath, A.; Hochman, S.; Geiger, J.D. 2000: Facilitation of NMDA-mediated calcium flux by the HIV-1 protein Tat involves tyrosine kinase-dependent modulation of the zinc site on NMDA receptors. Journal of Neurochemistry 74(Suppl ): S19
Zhang, L.; Tompkins, J.D.; Hancock, J.C.; Hoover, D.B. 2001: Facilitation of acetylcholine by substance P in guinea pig intrinsic cardiac ganglia. FASEB Journal 15(4): A472
Czeche, S.; Niebel, B.; Mutschler, E.; Lambrecht, G. 1999: Facilitation of acetylcholine release from myenteric neurones by alpha,beta-methylene ATP causes a contraction of the guinea-pig ileum via postjunctional M3 receptors. Life Sciences 64(6-7): 592
Suzuki, T.; Yasuda, M.; Ohbayashi, M.; Yamamoto, T. 2003: Facilitation of angiogenesis after cross-linking of intercellular adhesion molecule-1 on endothelial cells. Journal of Pharmacological Sciences 91(Suppl I): 160P
Kusters, H.C.; Klotzbach, J.M.; Parmar, S.S. 2001: Facilitation of anticonvulsant action of MMPQ* by calcium channel blockers. Journal of Molecular and Cellular Cardiology 33(6): A63
Esquinas Rychen, M.; Erni, B. 2002: Facilitation of bacteriophage lambda DNA injection by inner membrane proteins of the bacterial phosphoenol-pyruvate Carbohydrate phosphotransferase system. Saier, Milton H , Jr JMMB Symposium Series The bacterial phosphotransferase system 81-104
Anderson, M.E.; Wu, Y. 2000: Facilitation of cardiac L-type Ca2+ current is prevented by cytoskeletal disrupting agents. Biophysical Journal 78(1 Part 2): 461A
Nowicky, A.V.; Mcgregor, A.H.; Davey, N.J. 1999: Facilitation of cortically evoked responses in human erector spinae muscle during voluntary contractions. Journal of Physiology (Cambridge) 518P: 62P
Hattori, T.; Maehashi, H. 1999: Facilitation of dopamine release by propylene glycol in PC12 cells. Japanese Journal of Pharmacology 79(Suppl 1): 294P
Potier, S.; Psarropoulou, C. 2003: Facilitation of epileptiform discharges in immature rat neocortex by a concerted action of muscarinic receptors and gap junctions. Epilepsia 44(Suppl 9): 210
Hughes, S.W.; Cope, D.W.; Blethyn, K.; Crunelli, V. 2000: Facilitation of fast and slow oscillations in thalamocortical neurones by activation of group I metabotropic glutamate receptors. British Journal of Pharmacology 131(Proceedings Suppl): 45P
Davis, M. 2003: Facilitation of fear extinction by NMDA agonists. European Neuropsychopharmacology 13(Suppl 4): S172-S173
Mueller, D.; Afonso, V.M.; Stewart, J.; Pfaus, J.G. 2002: Facilitation of female-male mounting following amphetamine- or stress-induced behavioral sensitization. Hormones and Behavior 41(4): 481
Lewis, R.E.; Cruse, J.M.; Dilioglou, S.; Roe, D.L.; Blaine, M.C.; Chen, R.S.; Wallace, W.F. 1999: Facilitation of immune function and healing of pressure ulcers in spinal cord injury patients. FASEB Journal 13(5 Part 2): A663
Hasenoehrl, R.U.; Weth, K.; De Souza Silva, M.A.; Junghans, U.; Mueller, H.W.; Huston, J.P. 1999: Facilitation of learning and long-term ventral pallidal-cortical cholinergic activation by proteoglycan biglycan and chondroitin-4-sulphate. Society for Neuroscience Abstracts 25(1-2): 630
Mccormick, A.L.; Benjamin, R.; Pizzey, A.; Kyriakou, C.; Nathwani, A.C. 2003: Facilitation of lentivirus mediated gene transfer into primary human and murine progenitors by Antp peptide. Blood 102(11): 995a
Watanabe, J.; Fujii, T.; Kasahara, T.; Kawashima, K. 2004: Facilitation of lymphocytic cholinergic activity by interaction of T cells with antigen-presenting cells. Journal of Pharmacological Sciences 94(Suppl 1): 203P
Takimoto, A.; Yoshino, S. 2002: Facilitation of oral tolerance by auranofin. Japanese Journal of Pharmacology 88(Suppl 1): 121P
Devereaux, B.; Phillips, S.; Fogel, E.; Bucksot, L.; Fay, P.; Shelly, L.; Fein, S.; Lehman, G.; Sherman, S. 2000: Facilitation of pancreatic duct cannulation using synthetic porcine secretin. American Journal of Gastroenterology 95(9): 2475-2476
Ayoub, C.M.; Lteif, A.M.; Rizk, M.S.; Abu-Jalad, N.M.; Hadi, U.; Baraka, A.S. 2002: Facilitation of passing the endotracheal tube over the flexible fiberoptic bronchoscope using a Cook airway exchange catheter. Anesthesiology 96(6): 1517-1518
Arispe, N.J.; Doh, M.; Kurganov, B. 2004: Facilitation of peptide-induced liposomes aggregation by membrane-bound GM1 ganglioside. Biophysical Journal 86(1): 205a-206a
Machovich, R.; Komorowicz, E.; Kolev, K.; Owen, W.G. 1999: Facilitation of plasminogen activation by denatured prothrombin. Thrombosis Research 94(6): 389-394
Zimmermann, P.; Steinhübel, B.; Greim, C.A. 2001: Facilitation of pulmonary artery catheter placement by transesophageal echocardiography after tricuspid valve surgery. Anesthesia and Analgesia 93(1): 242-243
Hellerqvist, C.G.; Wamil, A.W.; Wamil, B.D. 2002: Facilitation of repair of neural injury with CM101/GBS toxin. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)
Akins, C.K.; Levens, N. 2002: Facilitation of sexually conditioned behaviors in male quail following cocaine-induced increases in locomotor activity. Drug and Alcohol Dependence 66(Suppl 1): S4-S5
Missal, M.; Heinen, S.J. 1999: Facilitation of smooth pursuit initiation by microstimulation of the supplementary eye fields. Society for Neuroscience Abstracts 25(1-2): 804
Oitzl, M.S.; Grootendorst, J.; Joels, M.; Reichardt, H.M.; Schuetz, G.; De Kloet, E.R. 2000: Facilitation of spatial learning requires DNA-binding of the glucocorticoid receptor. European Journal of Neuroscience 12(Suppl 11): 170
Hanash, A.M.; Levy, R.B. 2003: Facilitation of syngeneic donor hematopoietic progenitors by proliferating CD8+ T-cells is dependent on host conditioning and does not require expression of host MHC class I. Blood 102(11): 696a
Liang, X.; Jardemark, K.E.; Wang, R.Y. 1999: Facilitation of the N-metyl-D-aspartate responses in pyramidal cells of the medial prefrontal cortex by clozapine Role of protein kinase C. Society for Neuroscience Abstracts 25(1-2): 2048
Felmy, F.; Neher, E.; Schneggenburger, R. 2001: Facilitation of transmitter release studied by calcium-uncaging at a large central synapse. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R178
Thomas, T.J.; Thomas, R.M.; Antony, T.; Balabhadrapathruni, S.; Saminathan, M.; Shirahata, A.; Thomas, T. 1999: Facilitation of triplex DNA formation by bis polyamine analogs and breast cancer cell growth inhibition by polyamine analog-complexed triplex forming oligonucleotide. Proceedings of the American Association for Cancer Research 40: 19
Floresco, S.B.; Brar, K.H.S.; Phillips, A.G. 1999: Facilitation of working memory after long delays and impairment after short delays by administration of a dopamine D1 receptor agonist into the prefrontal cortex. Society for Neuroscience Abstracts 25(1-2): 889
Hellerqvist, C.G.; Neeman, M.; Wamil, B.D.; Abramovitch, R. 2003: Facilitation of wound healing with CM101/GBS toxin. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)
Mazia, N.C.; Chaneton, E.J.; Kitzberger, T. 2003: Facilitation vs apparent competition and the establishment of tree seedlings beneath nurse shrubs in northern Patagonian. Ecological Society of America Annual Meeting Abstracts 88: 222
Chaneton,E.J.; Mazia,C.N.; Kitzberger,T. 2010: Facilitation vs apparent competition insect herbivory alters tree seedling recruitment under nurse shrubs in a steppe-woodland ecotone. Journal Of Ecology (oxford): 2, 488-497
Thomson, A.M. 2000: Facilitation, augmentation and potentiation at central synapses. Trends in Neurosciences 23(7): 305-312
Machicote, M.E.; Branch, L.C.; Villarreal, D. 2002: Facilitation-inhibition Burrowing owls and their hosts in central Argentina. Ecological Society of America Annual Meeting Abstracts 87: 385
Goldman, I.David 2003: Facilitative carriers that transport folates and antifolates Energetics, structure/function, and role in drug efficacy in model tumor systems. Proceedings of the American Association for Cancer Research 44: 1379
Wiese, P.; Schroeppel, B.; Fink, M.; Banas, B.; Schloendorff, D.; Fischereder, M. 2000: Facilitative glucose transport in human peritoneal mesothelial cells under conditions mimicking CAPD. Kidney and Blood Pressure Research 23(3-5): 308-309
Larsen, K.I.; Falany, M.L.; Wang, W.; Williams, J.P. 2001: Facilitative glucose transporter GLUT2 is present in osteoclasts. Journal of Bone and Mineral Research 16(Suppl 1): S508
Page, T.; Ollerenshaw, M.; Hodgkinson, A.D.; Hammonds, J.C.; Demaine, A.G. 2003: Facilitative glucose transporter polymorphisms are associated with susceptibility to clear cell renal carcinoma. Journal of Urology 169(4 Suppl): 144
Neama, G.; Bell, S.; Richardson, S.; Carter, S.D.; Mobasheri, A. 2002: Facilitative glucose transporters 1, 3 and 9 are expressed in human articular cartilage. Journal of Physiology (Cambridge) 539P: 23P-24P
Concha, I.I.; Valenzuela, V.; Otth, C.; Trivino, C.; Rauch, M.C.; Alberdi, M. 1999: Facilitative hexose transport in pollen grain through transporters with structural and functional characteristics of GLUTs. FASEB Journal 13(7): A1339
Allard, J.; Alexandre, L.; Bernabe, J.; Benoit, G.; Droupy, S.; Giuliano, F. 2004: Facilitator proerectile activity of melanotan-II in anesthetized rat. Journal of Urology 171(4 Suppl): 427
Smith, S.R.; Reed, G.R.; Jaffe, D.M. 1999: Facilitators and barriers to obtaining follow-up care after an acute asthma ED visit. Pediatric Research 45(4 Part 2): 83A
Hoffmann, H.; Kupper, Z. 2002: Facilitators of psychosocial recovery from schizophrenia. International Review of Psychiatry 14(4): 293-302
Singewald, N.; Sinner, C. 2000: Facilitatory action of nitric oxide on stress-induced glutamate release in the locus coeruleus. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl): R31
Yuasa, N.; Li, S.; Mizota, A.; Hoshino, A.; Adachi Usami, E. 1999: Facilitatory and neurotoxic effects of ornithine on the ERGs of albino rats. IOVS Investigative Ophthalmology and Visual Science 40(4): S12
Maneuf, Y.P.; Mcknight, A.T. 2000: Facilitatory effect of calcitonin gene-related peptide on K+-evoked release of dopamine in the rat caudal striatum. British Journal of Pharmacology 129(Proceedings Suppl): 123P
Binns, K.E.; Salt, T.E. 2000: Facilitatory interactions between NMDA and group I metabotropic glutamate receptors in the thalamus. European Journal of Neuroscience 12(Suppl 11): 137
Pearson, T.; Frenguelli, B.G. 2000: Facilitatory role of beta-adrenoceptors in the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampal slice. Journal of Physiology (Cambridge) 528P: 74P-75P
Cronk, K.M.; Harrison, S.M.W.; Davis, B.M.; Albers, K.M.; Rice, F.L. 1999: Facilitory role of the p75 receptor in NGF/trkA signaling during the development of sensory and sympathetic innervation to the whisker pad. Society for Neuroscience Abstracts 25(1-2): 768
Forrest, G.; Robbins, D.; Simpson, J. 2002: Facility design for monoclonal antibody conjugate production. Abstracts of Papers American Chemical Society 224(1-2): BIOT 68
Martinez Ruiz, Epifanio 2002: Facility for preparing bakery and pastry products. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)
Shvalov, A.N.; Maltsev, V.P. 2002: Facility of Scanning Flow Cytometry in characterization of an individual bacterium. Cytometry Suppl (11): 91-92
Fernandes, M.; Sturm, R. 2010: Facility provision in elementary schools: correlates with physical education, recess, and obesity. Preventive Medicine 50 Suppl. 1: S30-S35
Eckelman,M.J. 2010: Facility-level energy and greenhouse gas life-cycle assessment of the global nickel industry. Resources, Conservation And Recycling: 4, 256-266
Tsuji, A.; Tamai, I.; Saheki, A.; Nakanishi, T.; Fukushima, M.; Matsuda, A.; Sasaki, T. 1999: Facillitative-transport of antitumor nucleosides, 3-ethynylcytidine and 3-ethynyluridine. Proceedings of the American Association for Cancer Research 40: 298
Steinbrueckner, B.; Singh, S.; Freney, J.; Kuhnert, P.; Pelz, K.; Aufenanger, J. 2001: Facing a mysterious hospital outbreak of bacteraemia due to Staphylococcus saccharolyticus. Journal of Hospital Infection 49(4): 305-307
Vallortigara, G.; Regolin, L. 2002: Facing an obstacle Lateralization of object and spatial cognition. Rogers, Lesley J , Andrew, Richard J Comparative vertebrate lateralization 383-444
Livermore, D.M. 2001: Facing antibiotic resistance. West Indian Medical Journal 50(1): 5-7
Chretien, J.R.; Pintore, M.; Piclin, N.; Ros, F.; Benfenati, E. 2003: Facing database mining challenges in ecotoxicity. Abstracts of Papers American Chemical Society 225(1-2): CINF 27
Eichler, J. 2003: Facing extremes Archaeal surface-layer proteins. Microbiology (Reading) 149(12): 3347-3351
Novak, S.; Zgaga, Z. 2004: Facing new frontiers in biotechnology. Periodicum Biologorum 106(2): 191-193
Percy,K.; King,J.; Matyssek,R. 2010: Facing the Future Evidence from Joint AspenFACE, SoyFACE and SFB 607 Meeting, Rhinelander, Wisconsin, USA, 2-4 April 2008. Environmental Pollution 8(4): 955-1104
Luo Wei; Zhao Xian Fu; Hu Zheng Yu 2001: Facing the challenge of the invasive species. Acta Hydrobiologica Sinica 25(5): 516-523
Block, S.M. 1999: Facing the truth Non-verbal and paralinguistic clues to deception and anxiety in adolescents. AAAS Annual Meeting and Science Innovation Exposition 165: A 109-A 110, 21-26 January
Alkaff, H.F. 2001: Facing the water scarcity problem in Yemen. Ecological Society of America Annual Meeting Abstracts 86: 247-248
Craig, T.; Timms, P. 2000: Facing up to social exclusion Services for homeless mentally ill people. International Review of Psychiatry 12(3): 206-211
Klamroth, V.; Herrmann, M.; Kennerknecht, I.; Horst, J. 2001: Facio-oculo-acustico-renal syndrome and diaphragmatic hernia in a consanguineous family. European Journal of Human Genetics 9(Suppl 1): P0401
Gilgenkrantz, H. 2003: Facio-scapulo-humeral atrophy A lack of repression?. M-S (Medecine Sciences) 19(1): 27-28
Barrett, K.A.; Forrester, J.D.; Tawil, R.; Griggs, R.C.; Figlewicz, D.A. 1999: Facioscapulohumeral Muscular Dystrophy myoblasts have increased susceptibility to oxidative stress. American Journal of Human Genetics 65(4): A231
Figlewicz, D.A.; Sowden, J.E.; Haefele, A.; Forrester, J.R.; Barrett, K.; Kavcic, V.; Tawil, R. 2002: Facioscapulohumeral dystrophy Premature activation of the myogenic program?. American Journal of Human Genetics 71(4 Suppl): 527
Lunt, P.W. 2000: Facioscapulohumeral muscular dystrophy Diagnostic and molecular aspects. Deymeer, Feza Monographs in Clinical Neuroscience; Neuromuscular Diseases: From Basic Mechanisms to Clinical Management 44--60
Krasnianski, M.; Neudecker, S.; Eger, K.; Schulte-Mattler, W.; Zierz, S. 2003: Facioscapulohumeral muscular dystrophy. the spectrum of clinical manifestations and molecular genetic changes. Der Nervenarzt 74(2): 151-158
Coprean, D.; Popescu, M.; Militaru, M.; Bosca, B. 2002: Facioscapulohumeral muscular dystrophy in Romania. European Journal of Human Genetics 10(Suppl 1): 260
Kogawa, K.; Lee, S.; Villanueva, J.; Marmer, D.; Filipovich, A.H. 2001: Facs analysis of perforin in cytotoxic lymphocytes from patients with Hemophagocytic Lymphohistiocytosis and their family members. Medical and Pediatric Oncology 36(3): 416
Lydic, R. 2002: Fact and fantasy about sleep and anesthesiology. Anesthesiology 97(5): 1050-1051
Forster, V.A. 2000: Fact sheets on US-approved genetically modified crops Inserted genes, approval status, commercial status. Abstracts of Papers American Chemical Society 219(1-2): AGFD 81
Sanchez Guerrero, J.; Mestanza Peralta, M.; Gonzalez Perez, M.; Durand Carbajal, M.; Jimenez, M.L.; Mendoza Fuentes, A.; Lara Reyes, P.; Cravioto, M.C. 1999: Factibility of clinical trials with exogenous estrogens in SLE The INNSZ study. Arthritis and Rheumatism 42(9 Suppl): S266
Rizzi, R.R.; Thomas, K.; Pilnik, S. 2000: Factious desaturation due to isosulfan dye injection. Anesthesiology 93(4): 1146-1147
Cohen, D.E.; Keon, T.P. 2000: Factitious arterial blood pressure measurements from automated oscillotonometer. Anesthesia and Analgesia 90(6): 1341-1342
Katz, S.L.; McGee, P.; Geist, R.; Durie, P. 2001: Factitious diarrhea: a case of watery deception. Journal of Pediatric Gastroenterology and Nutrition 33(5): 607-609
Aaron, C.K.; Stiles, P. 2003: Factitious digoxin toxicity from interference with an automated immunoassay. Journal of Toxicology. Clinical Toxicology 41(5): 678
Ravnik Oblak, M.; Koselj, M. 2000: Factitious hypoglycaemia due to surreptitious administration of insulin and oral hypoglycaemic drugs abuse. Diabetes Research and Clinical Practice 50(Suppl 1): S236
Imrie, F.R.; Church, W.H. 2003: Factitious keratoconjuctivitis. Eye 17(2): 256-258
Mundschenk, J.; Muehlen, I.; Duesing, R.; Vetter, H.; Kingreen, H.; Dralle, H.; Lehnert, H. 2001: Factitious pheochromocytoma in three members of a family. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S72
Gordon, E.M.; Anderson, W.F.; Hall, F.L. 2001: Factor 1X delivery method using bone marrow-derived cells. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)
Schiepers, C.; Czernin, J.; Hoh, C.K.; Nuyts, J.; Phelps, M.E.; Dahlbom, M. 2002: Factor Analysis for automatic determination of myocardial flow in 13N-ammonia PET studies. Journal of Nuclear Medicine 43(5 Suppl): 52P
Jaatinen, T.; Kanerva, J.; Saarinen Pihkala, U.M.; Lokki, M.L. 1999: Factor B expression in acute leukemia. Molecular Immunology 36(4-5): 315
Hegasy, G.; Friese, M.; Hellwage, J.; Jokiranta, S.; Meri, S.; Zipfel, P.F. 1999: Factor H and disease A complement regulator affecting vital body functions. Molecular Immunology 36(4-5): 281
Zipfel, P.F.; Hellwage, J.; Friese, M.A.; Hegasy, G.; Jokiranta, S.T.; Meri, S. 1999: Factor H and disease: a complement regulator affects vital body functions. Molecular Immunology 36(4-5): 241-248
Losse, J.; Zipfel, P.F.; Józsi, Mály. 2010: Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. Journal of Immunology 184(2): 912-921
Heinen, S.; Jozsi, M.; Noris, M.; Remuzzi, G.; Zipfel, P.F. 2003: Factor H associated HUS Mutated factor H proteins display complement regulatory activity but show reduced binding to C3b, heparin, and endothelial cells. Molecular Immunology 40(2-4): 193
Seeberger, H.; Cheng, Z.Z.; Hellwage, J.; Jozsi, M.; Ormsby, R.; Gordon, D.L.; Zipfel, P.F.; Meri, S.; Jokiranta, T.S. 2003: Factor H binding to endothelial cells is mediated by the carboxy-terminal heparin/glycosaminoglycan binding site. Molecular Immunology 40(2-4): 193
Vaziri Sani, F.; Iancu, R.; Hellwage, J.; Zipfel, P.F.; Papadopoulou, D.; Karpman, D. 2002: Factor H binds to and activates platelets. International Immunopharmacology 2(9): 1263
Hollenbeck, M.; Scheja, J.W.; Zotz, R.B.; Post, J.; Deppe, C.; Grabensee, B. 1999: Factor H concentration in patients with thrombotic microangiopathy Preliminary results. Kidney and Blood Pressure Research 22(4-6): 222
Neumann, H.P.H.; Bohnert Iwan, B.; Manuelian, T.; Riegler, P.; Zipfel, P.F. 2002: Factor H gene germline mutations in patients with atypical hemolytic uremic syndrome A registry based study. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 304A
Caprioli, J.; Bettinaglio, P.; Vasile, B.; Gamba, S.; Amadei, B.; Zipfel, P.F.; Orisio, S.; Sangalli, F.; Remuzzi, G.; Noris, M. 2000: Factor H gene mutations in familial hemolytic uremic syndrome. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 404A
Manuelian, T.; Hellwage, J.; Meri, S.; Caprioli, J.; Noris, M.; Neumann, H.P.H.; Remuzzi, G.; Zipfel, P.F. 2002: Factor H gene mutations in hemolytic uremic syndrome Reduced protein interactions reveal a role for microvascular damage and thrombus formation. International Immunopharmacology 2(9): 1239-1240
Sakaue, T.; Takeuchi, K.; Maeda, T.; Yamamoto, Y.; Nishi, K.; Ohkubo, I. 2010: Factor H in porcine seminal plasma protects sperm against complement attack in genital tracts. Journal of Biological Chemistry 285(3): 2184-2192
Goodship, J.A.; Buddles, M.R.H.; Richards, A.; Donne, R.L.; Warwicker, P.; Goodship, T.H.J. 2000: Factor H mutation in familial and sporadic hemolytic uremic syndrome. American Journal of Human Genetics 67(4 Suppl 2): 408
Richards, A.; Donne, R.; Buddles, M.; Warwicker, P.; Goodship, J.; Goodship, T. 2000: Factor H mutations in familial and sporadic HUS. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 412A
Richards, A.; Buddles, M.R.; Donne, R.L.; Goodship, J.A.; Goodship, T.H.J. 2002: Factor H mutations in haemolytic uraemic syndrome cluster in SCRs 18-20, a domain important for host cell recognition. Clinical Science (London) 103(1): 28P
Alexander, J.J.; Quigg, R.J. 2000: Factor H on rodent platelets functions as the immune adherence receptor. Immunopharmacology 49(1-2): 49
Perkins, S.; Skerka, C.; Neumann, H.P.H.; Zipfel, P.F. 2003: Factor H-associated hemolytic-uremic syndrome Structural consequences of disease-associated mutations. Molecular Immunology 40(2-4): 216
Hellwage, J.; Jarva, H.; Zipfel, P.F.; Meri, S. 2000: Factor H-related proteins interact with C-reactive protein. Immunopharmacology 49(1-2): 70
Hicks, R.M.; Reichmuth, D.; Lockey, R.F.; Bielsa, L.; Good, R.A.; Day, N.K. 2002: Factor I complement deficiency in an individual of parents with normal factor I. Journal of Allergy and Clinical Immunology 109(1 Suppl): S194-S195
Leitao, M.F.; Condino Neto, A.; Grumach, A.S.; Kirschfink, M. 2000: Factor I deficiency Evaluation in three generations of a Brazilian family. Immunopharmacology 49(1-2): 14
Ursin, S.A.; Yanamandra, K.; Rodriquez Paris, J.; Smith, M.; Napper, D.; Thurmon, T.F.; Chen, H.; Dhanireddy, R.; Bocchini, J.A.J.; Mills, G.M.; Glass, J. 2003: Factor II G20210A polymorphism and breast cancer. American Journal of Human Genetics 73(5): 403
Hallahan, T.W.; Gilbert, C.W. 1999: Factor IX -- polymeric conjugates. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Kaibara, M.; Iwata, H. 2002: Factor IX activation by erythrocyte membranes is a powerful trigger for thrombus formation under stagnant flow conditions. Biorheology 39(5): 654
Stafford, D.W.; Chang, J.L. 2003: Factor IX antihemophilic factor with increased clotting activity. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)
Mertens, K.; Lenting, P.J.hannes 2001: Factor IX binding peptides, derived from factor VIII and their use as inhibitors of blood coagulation. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)
Cho, Y.H.; Lee, C.H.; Shim, S.H.; Seo, H.K. 1999: Factor IX gene mutations in Korean hemophilia B patients. American Journal of Human Genetics 65(4): A212
Cho, Y.H.; Seo, H.K.; Kyhm, J.H.; Shin, E.S.; Lee, C.H. 2003: Factor IX mutations in Korean hemophilia B patients. American Journal of Human Genetics 73(5): 576
Clark, Anthony John 2000: Factor IX production in transgenic non-human mammals and factor IX DNA sequences with modified splice sites. Official Gazette of the United States Patent and Trademark Office Patents 1233(1)
Gonzalez Rubio, C.; Saboya, M.A.; Pascual Salcedo, D.; Fontan, G.; Lopez Trascasa, M. 1999: Factor J as an acute-phase reactant Its correlation with other inflammatory parameters in synovial fluid and in sera from burned patients. Molecular Immunology 36(4-5): 304
Srivastava, A.S.; Carrier, E. 2002: Factor Responsible for In Vivo Neutralization of T7 Phage Display Vector in the Blood of Mice. Blood 100(11): Abstract No. 5543
Bossone, A.; D'Angelo, F.; Santacroce, R.; De Lucia, D.; Margaglione, M. 2002: Factor V Arg2074Cys: a novel missense mutation in the C2 domain of factor V. Thrombosis and Haemostasis 87(5): 923-924
Lin, J.S.; Shen, M.C.; Tsai, W.; Lin, B.; Lin, B.B.; Hong, M.H. 2000: Factor V Arg306- Gly is not a risk factor for venous thrombophilia in Taiwanese Chinese. Fibrinolysis and Proteolysis 14(Suppl 1): 81
Moessmer, G.; Mueller, B.; Neumeier, D. 1999: Factor V Cambridge is absent or very rare in Southern Bavaria. Annals of Hematology 78(Suppl 1): A85
Ruiz Arguelles, G.J.; Garces Eisele, J.; Reyes Nunez, V.; Ramirez Cisneros, F.J. 2000: Factor V G1691A , prothrombin G20210A and methylenetetrahydrofolate reductase C677T gene polymorphism in thrombophilic Mexican mestizos. Blood 96(11 Part 2): 100b-101b
Pilch, J.; Gerhardt, A.; Zotz, R.B.; Goecke, T.; Beckmann, M.W.; Bender, H.G.; Scharf, R.E. 2001: Factor V G1691A and prothrombin G20210A are risk determinants of preeclampsia and HELLP syndrome. Annals of Hematology 80(Suppl 1): A53
Assanelli, D.; Ferrari, R.; Bollani, G.; Ettori, F.; Bonetti, P.; Bersatti, F.; Archetti, S.; Ruggeri, G.; Bonanome, A.; Martini, G. 1999: Factor V G1691A, apo E4 allele, hyperhomocysteinemia and MTHFR C677T in a young patient with myocardial infarction. Thrombosis and Haemostasis 82(3): 1196
Min, M.S.Y.ung; Tanser, L.; Skarzynski, J.; Johnson, R.J.; Fegan, C.D. 2001: Factor V HR2 haplotype in venous thrombosis and the normal population in the UK. British Journal of Haematology 113(Suppl 1): 14
Juul, K.; Tybjaerg-Hansen, A.; Nordestgaard, B.ør.G. 2002: Factor V Leiden: relation to fertility?. Lancet 359(9309): 894
Walker, I.D. 1999: Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?. Blood Reviews 13(1): 8-13
Bircan, R.; Erzik, C.; Akbas, F.; Guney, I.; Oral, E.; Cirakoglu, B. 2001: Factor V Leiden and factor II mutation frequencies in Turkish pregnant women; preliminary findings. European Journal of Human Genetics 9(Suppl 1): P0922
Doix, S.; Mahrousseh, M.; Jolak, M.; Laurent, Y.; Lorenzini, J.L.; Binquet, C.; Zeller, M.; Cottin, Y.; Wolf, J.E. 2003: Factor V Leiden and myocardial infarction: a case, review of the literature with a meta-analysis. Annales de Cardiologie et d'Angeiologie 52(3): 143-149
Lee, M.J.; Oddoux, C.; Maturi, J.; O'neill, L.; Funai, E.F.; Ostrer, H.; Lockwood, C. 2001: Factor V Leiden and prothrombin 20210 G-A mutations in association with severely growth restricted pregnancies. American Journal of Obstetrics and Gynecology 184(1): S131
Hayat, M.; Cawthray, N.; Catto, A.; Grant, P.J.; O'mahony, S. 2000: Factor V Leiden and prothrombin 20210A mutation in patients with inflammatory bowel disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1346
Garber, J.E.; Costantino, J.P.; Wickerham, D.L.; Berliner, N.; Wolmark, N. 2002: Factor V Leiden and prothrombin G20210A mutations and risk of thromboembolic events in NSABP P-1, the breast cancer prevention trial. Breast Cancer Research and Treatment 76(Suppl 1): S107
Adamczuk, Y.; Iglesias Varela, M.L.; Forastiero, R.; Martinuzzo, M.; Cerrato, G.; Pombo, G.; Carreras, L.O. 2000: Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population. Thrombosis and Haemostasis 83(3): 509-510
Zalavras, C.G.; Vartholomatos, G.; Dokou, E.; Malizos, K.N. 2002: Factor V Leiden and prothrombin gene mutations in femoral head osteonecrosis. Thrombosis and Haemostasis 87(6): 1079-1080
Jankowski, M.; Sanak, M.; Axenti, I.; Krzanowski, M.; Dropinski, J.; Nowakowski, T.; Brzostek, T.; Musial, J.; Tendera, M.; Szczeklik, A. 1999: Factor V Leiden and prothrombin variant 20210A in patients with premature arteriosclerosis. European Journal of Clinical Investigation 29(Suppl 1): 73
Papa, A.; Cianci, R.; Papa, V.; Cammarota, G.; Gasbarrini, A.; Gasbarrini, G. 2000: Factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1363
Sanders, M.E.; Rebbeck, T.R.; Litzky, L.A.; Leonard, D.G.B.; Pollak, E.S. 2002: Factor V Leiden but Not Prothrombin 20210A Mutation Associated with Massive Fatal Thromboembolic Events. Blood 100(11): Abstract No. 1047
Greiner, K.H.; Peetz, D.; Winkgen, A.; Ossendorf, M.; Prellwitz, W.; Pfeiffer, N.; Hafner, G. 2000: Factor V Leiden is a risk factor in central retinal vein occlusion. IOVS Investigative Ophthalmology and Visual Science 41(4): S468
Dizon Townson, D.; Nelson, L.; Baksh, L.; Varner, M.; Ward, K. 2000: Factor V Leiden may predispose fetuses to cerebral palsy. American Journal of Obstetrics and Gynecology 182(1 Part 2): S64
Barocci, S.; Fiordoro, S.; Valente, U.; Andorno, E.; Morelli, N.; Santori, G.; Bonifazi, L.; Barocci, F.; Antonelli, P.; Nocera, A. 2002: Factor V Leiden mutation and early liver graft loss. European Journal of Immunogenetics 29(2): 162
Guermazi, S.; Bahlous, A.; Labbane, N.; Abdelhak, S.; Dellagi, K. 2000: Factor V Leiden mutation and factor II Leiden mutation in a healthy subject without thrombosis antecedent. American Journal of Human Genetics 67(4 Suppl 2): 380
Go, A.S.; Reed, G.L.; Hylek, E.M.; Phillips, K.A.; Chang, Y.; Henault, L.E.; Selby, J.V.; Singer, D.E. 2001: Factor V Leiden mutation and risk of stroke in atrial fibrillation The anticoagulation and risk factors in atrial fibrillation study. Circulation 104(17): 2; 530
Mandala, M.; Curigliano, G.; Bucciarelli, P.; Ferretti, G.; Mannucci, P.M.; Colleoni, M.; Peruzzotti, G.; Severi, G.; Biffi, R.; Goldhirsch, A. 2003: Factor V Leiden mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Pathophysiology of Haemostasis and Thrombosis 33(Suppl 1): 89
Ferrari, M.F.; Cardillo, E.C.; Carrera, P.C.; Ugozzoli, L.A.U.; Lowery, J.D.L.; Wallace, R.B.W. 1999: Factor V Leiden mutation detection by a new DNA-based assay. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S163
Besnier, R.; Piette, J.C.; Becherel, P.A.; Ankri, A.; Aiach, M.; Frances, C. 2000: Factor V Leiden mutation in Sneddon syndrome. Journal of Autoimmunity 15(2): A42
El Karaksy, Hanaa; Al Shabrawi, Mortada; El Koofy, Nehal; El Hawary, Manal; Mostafa, Azza; Safy, Marwa; Aziz, Mona; Wilson, Manal; Ali, Hala; El Guizery, Afaf; A.Kader, Hassan H. 2003: Factor V Leiden mutation in children with portal vein thrombosis. Hepatology 38(4 Suppl 1): 415A
Hepner, M.; Roldan, A.; Pieroni, G.; Frontroth, J.P.; Serviddio, R.M.; Torres, A.F.; Sciuccati, G.; Bonduel, M. 1999: Factor V Leiden mutation in the Argentinian population. Thrombosis and Haemostasis 81(6): 989
Steiner, S.; Bartok, A.; Frommelt, F.; Minar, E.; Kopp, C.W. 2003: Factor V Leiden mutation is associated with increased risk for periprocedural neurological deficits in carotid stenting. Journal of the American College of Cardiology 41(6 Suppl A): 51A
Wright, M.; Goldin, R.; Hellier, S.; Hill, A.; Apple, R.; Cheung, S.; Thomas, H.; Thursz, M. 2002: Factor V Leiden polymorphism and the rate of fibrosis development in chronic Hepatitis C Virus infection. Clinical Science (London) 103(1): 41P
Pieroni, F.; Freitas, M.V.C.; Zago, M.A.; Araujo, A.G.; Tavella, M.H.; Louzada, P.Jr; Franco, R.F. 2002: Factor V Leiden, FII G20210A and MTHFR C677T and the risk of venous thromboembolism, arterial thrombosis and recurrent miscarriage in APS. Lupus 11(9): 605
Lee, M.J.; Ku, D.H. W.; Paidas, M.J.; Arkel, Y.S.; Rebarber, A.; Shah, M.; Thurston, A.; Mattis, S.; Davidson, B.; Mulholland, J.; O'niel, L.; Wein, R. 2002: Factor V Leiden, but Not Prothrombin Gene 20210 G-A Mutation, Is Associated with Severely Growth Restricted Pregnancies. Blood 100(11): Abstract No. 1024
Kapustin, S.; Kobilyanskaya, V.; Saltykova, N.; Kargin, V.; Papayan, L.; Blinov, M. 2000: Factor V Leiden, prothrombin G20210A and MTHFR C677T mutations are not prevalent in patients with peripheral arterial occlusive disease. Haemostasis 30(Suppl 1): 137
Reiner, A.P.; Rosendaal, F.R.; Reitsma, P.H.; Lemaitre, R.N.; Pearce, R.M.; Friedlander, Y.; Raghunathan, T.E.; Psaty, B.M.; Siscovick, D.S. 2002: Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons. American Journal of Cardiology 90(1): 66-68
Markowitz, R.B.; Kutlar, A. 1999: Factor V Rsa I polymorphism as a possible prognosticator of certain complications in Sickle Cell Disease. American Journal of Human Genetics 65(4): A333
Rosing, J.; Govers-Riemslag, J.W.; Yukelson, L.; Tans, G. 2001: Factor V activation and inactivation by venom proteases. Haemostasis 31(3-6): 241-246
Von Depka, M.; Tiede, A.; Eisert, R.; Trummer, A.; Ganser, A. 2003: Factor V and factor VIII activity as risk factors of venous thromboembolism. Blood 102(11): 209a
Ono, T.; Liu, N.; Makino, T.; Nakamura, T.; Matsuyama, K.; Kusano, H.; Muso, E.; Honda, G.; Sasayama, S. 1999: Factor V expression in the masangial fibrin production in experimental mesangioproliferative glomerulonephritis. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 534A
Blaszyk, H.; Bjornsson, J. 2000: Factor V gene mutation and morbid obesity in fatal postoperative acute pulmonary embolism. Laboratory Investigation 80(3): 4A
Okita, M.; Kunisaki, C.; Kurosawa, N.; Motizuki, Y.; Shinohara, K.; Negishi, Y.; Yamaguti, S.; Shimada, H.; Watanabe, S. 2000: Factor V inhibitor developed after the surgery of esophageal cancer. Nihon Shokakibyo Gakkai Zasshi 97(3): 327-330
E.D.frawy, S.R.; Johnson, T.M.; Hodge, W.G.; Kertes, P.J.; Leonard, B.C.; Lillycrap, D.P. 1999: Factor V leiden and activated protein C resistance in patients with central retinal vein occlusion. IOVS Investigative Ophthalmology and Visual Science 40(4): S933
Meyer, M.; Kutscher, G.; Brandt, A.; Vogel, G. 1999: Factor V leiden and prothrombin 20210A variant in clinical subgroups of venous thromboembolism Simultaneous detection of both risk factors by multiplex PCR and SSCP. Annals of Hematology 78(Suppl 1): A27
Mertens, K.; Meijerman, D.W.E.; Van Der Zwaan, C.; Bos, M.H.A. 2003: Factor V variants that are resistant against activated protein C may compensate for defects upstream in the coagulation cascade. Blood 102(11): 550a
Sodam, B.R.; Aziz, A.R.; Dugar, N.; Solinas, A. 2002: Factor VII Deficiency Associated with Gilbert Syndrome A Case Report. Blood 100(11): Abstract No. 3881
Makris, T.; Krespi, P.; Hatzizacharias, A.; Chronakis, E.; Tsoukala, C.; Triposkiadis, F.; Kyriakidis, M. 1999: Factor VII and factor XII plasma levels are elevated in healthy offspring of men with premature myocardial infraction. Journal of the American College of Cardiology 33(2 Suppl A): 274A-275A
Petersen, L.C.; Olsen, O.H.; Richter, S.L.; Jakobsen, P. 1999: Factor VII binding reagent. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1342
Richter, N.J.; Lestini, B.J.; Balu, R.; Marchant, R.E. 2001: Factor VII derived peptides for liposomal drug delivery in restenosis. FASEB Journal 15(4): A175
Husbyn, M.; Fischer, P.; Orning, L. 1999: Factor VII fragment 82-128 and its use in blood-clotting disorders. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Borensztajn, K.; Sobrier, M-Laure.; Fischer, A-Marie.; Chafa, O.; Amselem, S.; Tapon-Bretaudiere, J. 2003: Factor VII gene intronic mutation in a lethal factor VII deficiency: effects on splice-site selection. Blood 102(2): 561-563
Pedersen, A.H.; Andersen, K.V.; Bornaes, C. 2004: Factor VII or VIIa-like molecules. Official Gazette of the United States Patent and Trademark Office Patents 1287(3)
Ratti, A.; Kudaravalli, R.; Tidd, T.; Santacroce, R.; Margaglione, M.; Devoto, M.; Fortina, P.; Pollak, E.S. 2001: Factor VII promoter decanucleotide insert polymorphism not associated with decreased Factor VII activity in African American. European Journal of Human Genetics 9(Suppl 1): P0872
Nishiya, K.; Shima, M.; Saenko, E.L.; Hosokawa, K.; Sakurai, Y.; Suzuki, H.; Takeyama, M.; Tatsumi, K.; Yoshioka, A. 2003: Factor VIII A2 domain contains plasmin-binding site responsible for plasmin-catalyzed factor VIII inactivation. Blood 102(11): 542a-543a
Ansong, C.; Fay, P.J. 2003: Factor VIII A3 domain residues 1954-1961 contribute to both metal ion-independent and copper-coordinating interactions that facilitate subunit association. Blood 102(11): 540a
Sharathkumar, A.; Kern, M.; Stain, A.M.; Blanchette, V.S.; Carcao, M.D. 2002: Factor VIII Inhibitors in Mild Hemophiliacs Following Continuous Infusion of Recombinant Factor VIII Is There a Causal Association?. Blood 100(11): Abstract No. 1915
Thompson, C.; Stirling, D.; White, A.R.; Ludlam, C.A. 2002: Factor VIII Mutation Analysis of a Series of 65 Consecutive Patients A Rapid and Accurate Approach. Blood 100(11): Abstract No. 1920
Saenko, E.L.; Ananyeva, N.M.; Tuddenham, E.G.D.; Kemball-Cook, G. 2002: Factor VIIi - novel insights into form and function. British Journal of Haematology 119(2): 323-331
Minnema, Monique M.; Fijnheer, Rob; De Groot, Philip G.; Lokhorst, Henk M. 2002: Factor VIII Procoagulant Activity as Risk Factor for Deep Venous Thrombosis in Patients with Multiple Myeloma during Treatment with Thalidomide. Blood 100(11): Abstract No. 1532
Kalashnikova, L.; Berkovski, A.; Dobrynina, L.; Sergeeva, E.; Kozlov, A.; Alexandrova, E.; Nassonov, E. 2002: Factor VIII activity in patients with Sneddons Syndrome. Lupus 11(9): 601
E.B.tarny, H.S.; Othman, M.A.; Austen, B.; Bruty, S.; O'shaughnessy, D.F. 2001: Factor VIII analysis and thromboelastography in patients with retinal vein thrombosis. British Journal of Haematology 113(Suppl 1): 14
Henke, P.; Wakefield, T.W. 2003: Factor VIIi and race: a new dimension in hypercoagulability. Thrombosis and Haemostasis 90(5): 768-769
Kotitschke, R.; Kloft, M. 2001: Factor VIII binding to VWF multimers in FVIII products Comparative testing of FVIII products and detection methods for the determination of VWF multimers. Annals of Hematology 80(Suppl 1): A36
Calatzis, A.; Conell, B.; Domsch, C.; Schramm, W.; Spannagl, M. 2001: Factor VIII deficient plasma with and without von Willebrand factor No influence on the aPTT-based determination of patient-own factor VIII. Annals of Hematology 80(Suppl 1): A9
Chandy, M.; Jayandharan, G.; Shaji, R.V.; Nair, S.C.; George, B.; Mathews, V.; Srivastava, A. 2003: Factor VIII gene mutation analysis in 50 Indian patients with hemophilia A. Blood 102(11): 102b
Barthels, M.; Kraus, M.; Bohn, U.; Liese, B.; von Depka, M.; Eisert, R.; Ganser, A. 1999: Factor VIIi inhibitor-tests could be less sensitive than supposed. Vox Sanguinis 77(Suppl 1): 87-89
Peerlinck, K. 2000: Factor VIII inhibitors Pathogenesis and treatment. Haemostasis 30(1-2): 27-28
Bril, W.S.; Turenhout, E.A.M.; Van Den Brink, E.N.; Timmermans, S.M.H.; Lardy, N.M.; Van Lier, R.A.W.; Peters, M.; Voorberg, J. 2000: Factor VIII inhibitors in haemophilia A patients with the Arg593fwdarwCys mutation. Haemostasis 30(1-2): 84
Wong, P.K.; Bleasel, J.F.; Vaile, J.H.; York, J.R.; Rickard, K.A. 2000: Factor VIIi inhibitors in rheumatoid arthritis. Journal of Rheumatology 27(9): 2288-2289
Reipert, B.M.; Ahmad, R.U.; Turecek, P.L.; Schwarz, H.P. 2000: Factor VIII neutralizing antibodies in murine hemophilia A as a model for immunotherapeutic intervention studies. FASEB Journal 14(6): A1130
Mertens, K. 2000: Factor VIII structure and function Molecular sites involved in regulation of biological activity. Haemostasis 30(1-2): 27
Mertens, K.; Celie, P.H.; Kolkman, J.A.; Lenting, P.J. 1999: Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly. Thrombosis and Haemostasis 82(2): 209-217
Hemker, H.C.; Kessels, H.J.; Beguin, S.L. 2000: Factor VIIICa chromogenic assay. Official Gazette of the United States Patent and Trademark Office Patents 1237(2)
Brummel Ziedins, K.; Rivard, G.E.; Pouliot, R.L.; Butenas, S.; Gissel, M.; Parhami-Seren, B.; Mann, K.G. 2004: Factor VIIa replacement therapy in factor VIi deficiency. Journal of Thrombosis and Haemostasis: Jth 2(10): 1735-1744
Klocking, H.P.; Mahr, N.; Moller, S.; Heise, K.H.; Herdering, W. 2004: Factor VIIa inhibition by sulphated hyaluronic acids, naturally occurring humic acids and synthetic humic acid like polymers. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R102
Klingler, O.; Schudok, M.; Zoller, G.; Heinelt, U.; Defossa, E.; Matter, H.; Safar, P. 2002: Factor VIIa inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1265(5)
Klingler, O.; Schudok, M.; Nestler, H.P.; Matter, H.; Schreuder, H. 2004: Factor VIIa inhibitory urea derivatives, their preparation and their use. Official Gazette of the United States Patent and Trademark Office Patents 1283(1)
Orban, T.; Gogonea, V.; Kalafatis, M. 2003: Factor Va cleavage and inactivation by activated protein C The role of cleavage at Arg679. Blood 102(11): 544a
Safar, P.; Safarova, A.; Wildgoose, P. 2001: Factor Vlla inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1250(2)
Pertosa, G.; Grandaliano, G.; Gesualdo, L.; Soccio, M.; Schena, F.P. 2002: Factor X activates mononuclear cells in hemodialysis via specific protease-activated receptors Role of oxidative stress. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 216A
Himmelspach, M.; Schlokat, U.; Dorner, F.; Fisch, A.; Eibl, J. 2003: Factor X analogues with a modified protease cleavage site. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)
Himmelspach, M.; Pfleiderer, M.; Falkner, F.G.; Eibl, J.; Dorner, F.; Schlokat, U. 2003: Factor X deletion mutants and analogues thereof. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)
Sinha, D.; Marcinkiewicz, M.; Walsh, P.N. 2003: Factor XI/G326C is functionally but not structurally identical to factor XI. Blood 102(11): 304a
Becker, R.C.; Li, Y.F.; Spencer, F.A. 2001: Factor XII activation in acute coronary syndromes Fundamental basis for pharmacological targeting of the intrinsic coagulation cascade. Journal of the American College of Cardiology 37(2 Suppl A): 313A-314A
Sato-Matsumura, K.C.; Matsumura, T.; Hayashi, H.; Atsumi, T.; Kobayashi, H. 2000: Factor XIi deficiency: a possible cause of livedo with ulceration?. British Journal of Dermatology 143(4): 897-899
Grey, M.; Shiach, C. 1999: Factor XII deficiency associated with a bleeding tendency?. Blood Coagulation and Fibrinolysis 10(8): 543
Helft, G.; Le Feuvre, C.; Metzger, J.P.; Vacheron, A.; Monsuez, J.J.; Lachurie, M.L.; Ahlenc-Gelas, M. 2000: Factor XIi deficiency associated with coronary stent thrombosis. American Journal of Hematology 64(4): 322-323
Lorand, L. 2001: Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Annals of the new York Academy of Sciences 936: 291-311
Zheng, H.; Butt, C.; Randell, E.; Porter, M.; Parfrey, P.; Xie, Y. 2001: Factor XIII V34L, factor V leiden, and prothrombin G20210A; relationship of common gene variants of blood coagulation factors to risk of myocardial infarction. European Journal of Human Genetics 9(Suppl 1): P1368
Pintao, M.C.rolina T.; Reges, R.V.; Araujo, A.G.; Tavella, M.H.; Zago, M.A.; Franco, R.F. 2002: Factor XIII Val34Leu and His95Arg Polymorphisms and the Risk of Deep Venous Thrombosis. Blood 100(11): Abstract No. 1039
Grant, P.J.; Kohler, H.P.; Catto, A.; Stickland, M.H. 1999: Factor XIII Val34Leu and atherothrombotic disorders Gene-environment interactions and vascular risk. Fibrinolysis and Proteolysis 13(Suppl 1): 51-52
Balogh, I.; Katona, E.; Karpati, L.; Pfliegler, G.; Muszbek, L. 2000: Factor XIII Val34Leu polymorphism Frequency in familial thrombophilia patients and the lack of its effect on plasma FXIII level and activity. Fibrinolysis and Proteolysis 14(Suppl 1): 80
Diz Kucukkaya, R.; Hancer, V.S.; Inanc, M.; Nalcaci, M.; Pekcelen, Y. 2003: Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome. Blood 102(11): 315a
Moessmer, G.; Mueller, B.; Artmann, A. 2001: Factor XIII Val34Leu polymorphism in women with a history of preeclampsia or HELLP syndrome Preliminary results. Annals of Hematology 80(Suppl 1): A48
Kohler, H.P.; Ariëns, R.A.; Mansfield, M.W.; Whitaker, P.; Grant, P.J. 2001: Factor XIIi activity and antigen levels in patients with coronary artery disease. Thrombosis and Haemostasis 85(3): 569-570
Salge, U.; Daubner, E.; Heiden, M.; Seitz, R. 2000: Factor XIIi does not stimulate growth of human cultured tumor cells. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(2): 217-218
Pintao, M.C.; Reges, R.V.; Tavella, M.H.; Araujo, A.G.; Morelli, V.M.; Lourenco, D.M.; Maffei, F.H.A.; Zago, M.A.; Franco, R.F. 2003: Factor XIII gene variation and the risk of venous thrombosis. Blood 102(11): 314a-315a
Stemmelin, G.R.; Duboscq, C.; Shanley, C.; Ceresetto, J.; Rabinovich, O.; Schamun, A.; Gutierrez, M.; Mendizabal, G.; Doti, C.; Castedo, M.G.; Melgar, M.; Bullorsky, E.O. 2002: Factor XIII in Bone Marrow Transplantation. Blood 100(11): Abstract No. 3874
Cruickshank, M.; Mackinnon, K. 2000: Factor XIII inhibitor response to cyclosporine. Haemostasis 30(Suppl 1): 196
Pihusch, R.; Pihusch, M.; Penovici, M.; Murmann, K.; Goehring, P.; Kolb, H.J.; Hiller, E.; Ostermann, H. 2001: Factor XIII levels in patients with graft versus host disease of the gut after haematopoietic stem cell transplantation. Annals of Hematology 80(Suppl 1): A53
Noll, T.; Wozniak, G. 2002: Factor XIII prevents capillary leakage in children undergoing surgery of congenital heart disease. Circulation 106(19): II595
Wozniak, G.; Noll, T.; Akintürk, H.; Thul, J.; Müller, M. 2001: Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Annals of the new York Academy of Sciences 936: 617-620
Chatterjee, T.; Schroder, V.; Mehta, H.; Wenaweser, P.; Wallmann, D.; Steiner, M.; Windecker, S.; Eberli, F.; Meier, B.; Kohler, H.P. 2001: Factor XIII transglutaminase activity and antigen levels in patients with coronary artery disease investigated by angiography. European Heart Journal 22(Abstract Suppl): 675
Fair, K.P.; Patterson, J.W. 1999: Factor XIIIA expression in the fibromatoses. Journal of Cutaneous Pathology 26(9): 468
Sotto, Mirian Nacagami 2004: Factor XIIIa positive dermal dendrocytes in American tegumentary leishmaniasis cutaneous tissue response. Revista do Instituto de Medicina Tropical de Sao Paulo 46(4): 208
Walenga, J.M.; Jeske, W.P.; Hoppensteadt, D.; Fareed, J. 2004: Factor Xa inhibitors. Methods in Molecular Medicine 93: 95-117
Wittpoth, M.; Bretschneider, E.; Braun, M.; Glusa, E.; Schror, K. 1999: Factor Xa-induced activation of mitogen-activated protein kinases in human vascular smooth muscle cells is independent of endogenous platelet-derived growth factor release. Circulation 100(18): 1; 616
Hajian Tilaki, K.O. 2002: Factor affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran. International Journal of Cancer Suppl (13): 241
Dantu, S. 2010: Factor analysis applied to a geochemical study of soils from parts of Medak and Sangareddy areas, Medak district, Andhra Pradesh, India. Environmental Monitoring and Assessment 162(1-4): 139-152
Schiepers, C.; Hoh, C.; Nuyts, J.; Wu, H.M.; Phelps, M.; Dahlbom, M. 2001: Factor analysis for automatic generation of in and output functions in oncological PET studies. Journal of Nuclear Medicine 42(5 Suppl): 189P
Kim, K.M.; Watabe, H.; Kudomi, N.; Hayashi, T.; Lee, J.S.; Hayashida, K.; IIda, H. 2003: Factor analysis for extracting tissue component in 15O2 gas PET study. Journal of Nuclear Medicine 44(5 Suppl): 251P
Schiepers, C.; Hoh, C.K.; Seltzer, M.A.; Phelps, M.E.; Dahlbom, M. 2000: Factor analysis for quantification of 11C-acetate PET in primary prostate cancer. Journal of Nuclear Medicine 41(5 Suppl): 100P
Freedman, N.; Chisin, R.; Rubinstein, R.; Shoshan, Y.; Siegal, T.; Buvat, I. 2002: Factor analysis in the evaluation of dynamic PET brain tumor imaging with 11C-choline. Journal of Nuclear Medicine 43(5 Suppl): 248P
Martus, P.; Korth, M.; Juenemann, A.; Wisse, M.; Horn, F.; Jonas, J. 1999: Factor analysis is a useful tool in the evaluation of diagnostic procedures in glaucoma. IOVS Investigative Ophthalmology and Visual Science 40(4): S279
Chen, M.K.; Aleksic, S.; Samal, M.; Kerenyi, L.; Vaterlein, O.; Ricaurte, G.; Szabo, Z. 2000: Factor analysis of dynamic PET studies of the serotonin transporter in idiopathic Parkinsons disease. Journal of Nuclear Medicine 41(5 Suppl): 138P
Vaterlein, O.; Szabo, Z.; Samal, M.; Kerenyi, L.; Scheffel, U.; Ricaurte, G. 1999: Factor analysis of dynamic PET studies performed in healthy individuals and in MDMA users. Society for Neuroscience Abstracts 25(1-2): 715
Leon, V.; Ponce, R.; Gonzalez Mazo, E.; Forja, J.M.; Gomez Parra, A. 1999: Factor analysis of linear alkylbenzene sulphonate vertical distribution in coastal sediments of Cadiz Bay. Boletin Instituto Espanol de Oceanografia 15(1-4): 509-516
Saxby, B.K.; Harrington, F.; Mckeith, I.G.; Wesnes, K.; Ford, G.A. 2000: Factor analysis of the cognitive drug research assessment battery in elderly hypertensives. Journal of Psychopharmacology 14(3 Suppl): A47
Schutte, A.J.; Van Der Flier, S.; Heukels, A.J. 2004: Factor analysis of the onset of therapeutic effect of mirtazapine versus SSRIs A meta-analysis on data of more than 2500 patients. Journal of Affective Disorders 78(Suppl 1): S127-S128
Poulsen, P.; Vach, K.; Del Prato, S.; Beck Nielsen, H. 1999: Factor analysis of the variables included in the metabolic syndrome. Diabetologia 42(Suppl 1): A61
Hanson, R.L.; Imperatore, G. 1999: Factor analysis of variables related to the metabolic syndrome in Pima Indians. Diabetes 48(Suppl 1): A167
Seo, K.; Lee, J.S.; Lee, D.S.; Yeo, J.S.; Ahn, J.Y.; Noh, T.W.; Chung, J.K.; Lee, M.C. 2001: Factor analysis on 15O water dynamic PET images of human kidneys for the noninvasive quantification of the renal cortical blood flow. Journal of Nuclear Medicine 42(5 Suppl): 40P
Schutte, A.J.; Vester Blokland, E. 2003: Factor analysis on onset of therapeutic effect of mirtazapine fast dissolving tablets versus sertraline. European Neuropsychopharmacology 13(Suppl 4): S251
Iglesius, G.; Schutte, A.J.; Vester Blokland, E.; Van Der Flier, S.; Harmsen, H.; Rapid Study Group 2004: Factor analysis on onset of therapeutic effect of mirtazapine orally disintegrating tablets versus sertraline. Journal of Affective Disorders 78(Suppl 1): S122
Hussein, M.; Mooij, J.; Roujouleh, H. 2000: Factor analysis, including antihypertensive medication, on the outcome of pregnancy in pregnancy-associated hypertension. Journal of Hypertension 18(Suppl 4): S50
Walker, S.C.; Shepherd, J.M.; Cancio, L.C.; Goodwin, C.W. 1999: Factor analytic investigation of blood gases in a large burn population. Journal of Burn Care and Rehabilitation 20(1 Part 2): S200
Bauman, L.E.; Sinsheimer, J.S.; Almasy, L.; Blangero, J.; Lange, K. 2001: Factor analytic methods in QTL mapping. American Journal of Human Genetics 69(4 Suppl): 531
Handmaker, N.S.; Shaw, P.K.; Tonigan, J.S. 2000: Factor analytic structure and relationship to substance abuse of the audit with pregnant drinkers. Alcoholism Clinical and Experimental Research 24(5 Suppl): 102A
Czyczylo, I.; Dubert, F. 2000: Factor controlling the dynamics of pod growth-rate in field bean. Plant Physiology and Biochemistry (Paris) 38(Suppl): s51
Kuhrts, A.M.; Huang, J.K.; Gessner, R.V.; Keudell, K.C. 2002: Factor from Kluyveromyces marxianus NRRL Y-8281 enhances biotransformation of oleic acid to 7,10-dihydryoxy-8 -octadecenoic acid by Pseudomonas aerugionsa. Transactions of the Illinois State Academy of Science 95(Suppl): 94
Obraztsov, I.F.; Kuz'min, V.M.; Khanin, M.A. 2002: Factor hageman deficiency Coagulation dynamics Mathematical model. Doklady Akademii Nauk 386(1): 127-129
Chailakhyan, R.K.; Latzinik, N.V.; Shamsudinov, A.G.; Gerasimov, Y.V.; Kuralesova, A.I.; Genkina, E.N.; Chailakhyan, M.R. 2002: Factor having influence on cloning efficiency of fibroblasts colonies in human bone marrow cultures. Doklady Akademii Nauk 382(3): 417-420
Kovalchuk, L.V.; Khoreva, M.V.; Gankovskaya, L.V.; Sokolova, Y.V. 2000: Factor inhibiting macrophageal migration A cytokine, hormone, immunomodulator?. Immunologiya 4: 4-9
Jimenez, R.; Sierra, M.J.; Saez, T.; Gil, A. 2000: Factor related to hypertension control among pharmacologically treated hypertensive patients. American Journal of Hypertension 13(4 Part 2): 252A-253A
Brankin, V.; Webb, R.; Hunter, M.G. 1999: Factor secreted by the porcine oocyte modulate granulosa cell growth and steroidogenesis. Journal of Reproduction and Fertility Abstract Series 23: 28
Marshall, S.J.; Sallis, J.F.; Mckenzie, T.L.; Conway, T.L.; Pampalone, S.Z.; Powers, H. 1999: Factor structure and correlates of sedentary behavior of children in grades 6-8. Medicine and Science in Sports and Exercise 31(5 Suppl): S175
Lynch, K.G.; Martin, C.S.; Chung, T. 2000: Factor structure of DSM-IV alcohol use disorder symptoms in a clinical sample of adolescents. Alcoholism Clinical and Experimental Research 24(5 Suppl): 75A
Rauch, B.H.; Bretschneider, E.; Braun, M.; Schroer, K. 2002: Factor-Xa cleaves secreted pro-matrix metalloproteinase-2 and releases active matrix metalloproteinase-2 from human vascular smooth muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R99
Cuccaro, M.; Bass, M.P.; Abramson, R.K.; Ravan, S.A.; Wright, H.H.; Wolpert, C.M.; Donnelly, S.L.; Pericak Vance, M.A. 2000: Factor-analysis of behavioral characteristics in Austistic Disorder. American Journal of Human Genetics 67(4 Suppl 2): 302
Alary, C.; Demougeot-Renard, H.él.èn. 2010: Factorial Kriging Analysis as a tool for explaining the complex spatial distribution of metals in sediments. Environmental Science and Technology 44(2): 593-599
Uhlig,S.; Gowik,P. 2010: Factorial interlaboratory tests for microbiological measurement methods. Journal Fur Verbraucherschutz Und Lebensmittelsicherheit: 1, 35-46
Peterson, L.E.; Lau, K. 2001: Factorial moments analysis of intermittency in gene expression on cDNA microarrays. American Journal of Human Genetics 69(4 Suppl): 471
Diebold, B.; Delouche, A.; Raffoul, H.; Diebold, H.; Abergel, E.; Frouin, F. 2003: Factorial parametric imaging of the left-ventricular contraction Validation of a new tool for assessing segmental wall motion abnomalities. European Heart Journal 24(Abstract Suppl): 207
Mann, K.; Ackermann, K. 1999: Factorial structure of the obsessive compulsive drinking scale in alcohol dependent inpatients. Alcoholism Clinical and Experimental Research 23(5 Suppl): 42A
Motl, R.W.; Pate, R.R.; Trost, S.G.; Saunders, R.; Dowda, M.; Felton, G.; Ward, D.S.; Dishman, R.K. 2000: Factorial validity and invariance of social-cognitive measures in adolescent girls. Medicine and Science in Sports and Exercise 32(5 Suppl): S115
Suzuki, K.; Nishijima, T. 2003: Factorial validity of a Soccer Defending Skill. Medicine and Science in Sports and Exercise 35(5 Suppl): S194
Perotti, C.G.; Bernuzzi, S.; Fante, C.D.; Viarengo, G.M.; Bergamaschi, P.; Bellotti, L.; Maliardi, V.; Locatelli, F.; Salvaneschi, L. 2002: Factors Affecting Recovery of CD34 Positive Cells Employing the Clini Macs Immunoselection Device. Blood 100(11): Abstract No. 5251
Milone, G.F.G.; Tornello, A.; Indelicato, F.; Moschetti, G.; Guido, G.; Consoli, U.; Giustolisi, R. 2002: Factors Associated with Fever after High Dose Chemotherapy and Autologous Hematopoietic Rescue. Blood 100(11): Abstract No. 5356
Gluckman, E.; Rocha, V.; Chevret, S.; Michel, G.; Sanz, G.; Locatelli, F.; Ortega, J.; Pasquini, R.; Chan, K.W.; Arcese, W. 2002: Factors Associated with Outcome of Unrelated Cord Blood Transplant Guidelines for Donor Choice An Eurocord Study. Blood 100(11): Abstract No. 2527
Engelhardt, M.; Bertz, H.; Behringer, D.; Lubbert, M.; Finke, J. 2002: Factors Influencing Collection and Outcome in Primary High-Risk and Relapsed Lymphoma Prospective Analysis of Autologous Hematopoietic Stem Cell Transplantation in 202 Lymphoma Patients. Blood 100(11): Abstract No. 3317
Nagamura Inoue, T.; Shioya, M.; Sugo, M.; Cui, Y.; Takahashi, A.; Takada, K.; Tomita, S.; Iwamoto, U.; Tokushima, Y.; Taguchi, A.; Zheng, Y.; Nagayama, H. 2002: Factors Influent on Incidence and Speed of Engraftment of Unrelated Cord Blood Transplantation in 46 Japanese Adult Patients with Units Shipped from Tokyo Cord Blood Bank Influence of the Dose of CD 34 + Cell and Colony Forming Cells. Blood 100(11): Abstract No. 5443
Majhail, N.S.; Mossad, S.B.; Bolwell, B.J. 2002: Factors Predicting Acute Bacterial Meningitis in Bone Marrow Transplant Recipients. Blood 100(11): Abstract No. 5321
Moadsiri, A.; Polchert, D.; Napoles, P.; Garcia, C.; Karavitis, J.; Maniotis, A.; Bartholomew, A. 2002: Factors Which Influence Mesenchymal Stem Cell Migration in Response to Tissue Injury. Blood 100(11): Abstract No. 2059
Toscano, L.C.; Boica Junior, A.L.; Maruyama, W.I. 2002: Factors acting on Bemisia tabaci B biotype oviposition in tomato. Neotropical Entomology 31(4): 631-634
Waters, S.B.; Akman, S.A. 1999: Factors affecting 5-methylcytosine to thymine transitions in the p53 gene of colorectal cancers. Dizdaroglu, M, Karakaya, A E NATO ASI Series Series A Life Sciences; Advances in DNA damage and repair: Oxygen radical effects, cellular protection, and biological consequences: 484-485
ChoiWonSil; ParkMiJin; LeeHakJu; ChoiInGyu; KangHaYoung 2010: Factors affecting Acer mono sap exudation Kwangyang region in Korea. Mokchae Konghak = Journal Of The Korean Wood Science And Technology: 1, 66-74
Huffman, Fatma G.; Al Haifi, Ahmad R. 2002: Factors affecting BMI and hemoglobin levels of mothers and infants in Kuwait. FASEB Journal 16(4): A279
Hayes, J.A.; Bair, C. 2003: Factors affecting E coli growth in limed versus anaerobically digested sludge. Journal of the Pennsylvania Academy of Science 76(Abstract and Index Issue): 118-119
Bonanome, A. 1999: Factors affecting LDL cholesterol reduction Unsaturated fatty acids. European Heart Journal 1(Suppl 5): S24-S28
Messa, P.; Gropuzzo, M.; Turrin, D.; Toso, C.; Mioni, G.; Cannella, G. 1999: Factors affecting Leptin levels after renal transplantation. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 709A
Lou, J.S.; Reeves, A.; Benice, T. 2002: Factors affecting Quality of Life in patients with amyotrophic lateral sclerosis. Neurology 58(7 Suppl 3): A198
Hegeman, C.E.; Reed, M.L.; Peeters, N.M.; Lyi, S.B.; Hanson, M.R. 2001: Factors affecting RNA editing in chloroplasts. Plant Biology (Rockville) : 153
Qiu, H.; Fujiwara, E.; Oshima, K.; Inana, G.; Parel, J.M.; Lam, B.; Hamasaki, D.I. 2001: Factors affecting a-wave latency of the rat ERG. IOVS Investigative Ophthalmology and Visual Science 42(4): S181
Maleckar, J.R.; Fossceco, S.; Katkocin, D. 1999: Factors affecting ability of experimental vaccines to protect guinea pigs against lethal challenge with diphtheria toxin. Biologicals: Journal of the International Association of Biological Standardization 27(2): 185
Armstrong, S.; Johnson, R.J.; Briggs, J.D.; Ansell, D.; Belger, M.A.; Sadek, S.; Rudge, C.J.; Feest, T.G. 2002: Factors affecting access of adult patients to the UK renal transplant waiting list. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 299
Lee, H.Y.; Yoo, T.H.; Hwang, J.H.; Song, H.Y.; Roh, H.; Shin, S.K.; Kang, S.W.; Choi, K.H.; Han, D.S. 1999: Factors affecting accurate quantitation of proteinuria using protein/creatinine ratio in random urine specimens. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 108A
Larowe, S.D.; Malcolm, R.J.; Anton, R.A.; Drobes, D.J.; Noll, E.; Morris, M. 2003: Factors affecting acoustic startle in alcoholics undergoing acute alcohol withdrawal. Alcoholism Clinical and Experimental Research 27(5 Suppl): 94A
Ospanova, T.; Kotulevich, N. 2002: Factors affecting adequacy of hemodyalysis. International Journal of Artificial Organs 25(7): 710
Lafeuillade, A. 2001: Factors affecting adherence and convenience in antiretroviral therapy. International Journal of Std and Aids 12(Suppl 4): 18-24
Kitimbo, D.W.; Lamunu, M.; Najjemba, R.; Muru, M.; Mugabi, B. 2000: Factors affecting adherence to anti-tuberculosis treatment in Jinja district-Uganda. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 173
Petri,C.; Scorza,R. 2010: Factors affecting adventitious regeneration from in vitro leaf explants of Improved French plum, the most important dried plum cultivar in the USA. Annals of Applied Biology 6(1): 79-89
Jain, J.K.; Khan, F.H.; Singh, A. 2000: Factors affecting age at first calving in Jersey. Indian Veterinary Medical Journal 24(3): 239-240
Sethi, C.P.; Khan, F.H.; Singh, A. 2001: Factors affecting age at first calving in Sahiwal. Indian Veterinary Medical Journal 25(1): 61-62
Davies, K.P.; Laksmipathy, A.; Melman, A.; Christ, G. 2003: Factors affecting alternative splicing of the Slo gene in urogenital smooth muscle Implications on physiology and function. Journal of Urology 169(4 Suppl): 308
Auger, P.; Tixier, M.S.; Kreiter, S.; Fauvel, G. 1999: Factors affecting ambulatory dispersal in the predaceous mite Neoseiulus californicus. Experimental and Applied Acarology 23(3): 235-250
Chakraborty, R.; O'connor, S.M.; Coates, J.D. 2000: Factors affecting anaerobic hydrocarbon biodegradation. Abstracts of the General Meeting of the American Society for Microbiology 100: 584
Tanaka, H.; Hayashi, Y.; Nakamura, S. 1999: Factors affecting annual incidence of habu bites, and how residents develop and transfer cognition of high-risk sites. Rodda, G H, Sawai, Y, Chiszar, D, Tanaka, H Problem snake management: The habu and the brown treesnake 139-148
Sharp, J.M.; Doran, P.M. 2001: Factors affecting antibody accumulation and stability in plant cell and organ cultures. Abstracts of Papers American Chemical Society 221(1-2): BIOT 22
Brown,M.W.; Short,B.D. 2010: Factors affecting appearance of stink bug injury on apple. Environmental Entomology: 1, 134-139
Tabelin,C.B.; Igarashi,T.; Tamoto,S. 2010: Factors affecting arsenic mobility from hydrothermally altered rock in impoundment-type in situ experiments. Minerals Engineering: 3, 238-248
Wulfeck-Kleier, K.A.; Ybarra, M.D.; Speth, T.F.; Magnuson, M.L. 2010: Factors affecting atrazine concentration and quantitative determination in chlorinated water. Journal of Chromatography. a 1217(5): 676-682
Ibrahim, S.A.; Hassan, O.A.; Seo, C.W.; Murad, Y.; Worku, M.; Shahbazi, G. 2003: Factors affecting autoaggregation behavior of bifidobacteria. Journal of Dairy Science 86(Suppl 1): 360-361
Young, J.C.; Edwards, F.G. 2004: Factors affecting ballasted flocculation reactions, James C Young and Findlay G Edwards, 75, 263 - Closure. Water Environment Research 76(3): 285
Billing, A.W.T.; Mccaw, S.T.; Thomas, D.Q.; Lagally, K.M.; Medema, H.C. 2003: Factors affecting bar kinematics among women performing the free weight bench press. Medicine and Science in Sports and Exercise 35(5 Suppl): S62
Kirchofer, K.S.; Calkins, C.R.; Eskridge, K.M.; Hanson, D.J. 2001: Factors affecting beef color development over time. Journal of Animal Science 79(Suppl 2): 58
Mayor, D.J.; Zuur, A.F.; Solan, M.; Paton, G.I.; Killham, K. 2010: Factors affecting benthic impacts at Scottish fish farms. Environmental Science and Technology 44(6): 2079-2084
Tomazic Jezic, V.J.; Lucas, A.D.; Sanchez, B.A. 2003: Factors affecting binding of natural rubber latex proteins to glove dusting powder. Toxicological Sciences 72(S-1): 229-230
Logan, B.E.; Kim, K.; Mulvaney, P.; Miller, J.; Wu, J.; Zhang, H. 1999: Factors affecting biodegradation of perchlorate-contaminated waters. Abstracts of Papers American Chemical Society 218(1-2): ENVR 58
YangHuiMin; LiMingHua; WangKaiJun; ChangLiChun 2010: Factors affecting bioleaching of heavy metals from animal excrement. Journal Of Ecology And Rural Environment: 1, 73-77
Fritz, K.M.; Feminella, J.W. 2002: Factors affecting biomass and biomass allocation in the riverine macrophyte Justicia americana Vahl. Ecological Society of America Annual Meeting Abstracts 87: 132
Jadhav, S.; Qureshi, M.I.; Khan, F.H.; Nanavati, S. 2001: Factors affecting birth weight in CorriedaleXSonadi crosses. Indian Veterinary Medical Journal 25(1): 59-60
Rousham, E.K.; Gracey, M. 2000: Factors affecting birthweight of indigenous Australians in the Kimberley region of north-west Australia. Annals of Human Biology 27(5): 535-536
Gamble, M.V.; Blaner, W.S. 2000: Factors affecting blood levels of vitamin A. Livrea, M A Author Molecular and Cell Biology Updates Vitamin A and retinoids: An update of biological aspects and clinical applications 1-16
Sabouret, P.; Brudi, P.; Zannad, F. 2003: Factors affecting blood pressure normalization in a population of 9331 hypertensive patients Results from the PACTE study. American Journal of Hypertension 16(5 Part 2): 61a-62a
Horyl, B.G.J.; Suarez, F.; Garabedian, M. 1999: Factors affecting bone demineralisation after long term successful kidney transplantation. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 758A